|
|
|
Scientific Literature, cholestasis
-
Aanpreung P, Laohapansang M, Ruangtrakool R, Kimhan J 2005 Neonatal cholestasis in Thai infants.
J. Med. Assoc. Thai. 88 Suppl. 8: S9-S15.
-
Abbasi S, Stewart DL, Radmacher P, Adamkin D 2008 Natural course of cholestasis in neonates on extracorporeal membrane oxygenation (ECMO): 10-year experience at a single institution.
ASAIO J. 54: 436-438.
-
Abdel-Ghaffar YT, Amin E, Abdel-Rasheed M, Fouad HH 2003 Essential fatty acid status in infants and children with chronic liver disease.
East. Mediterr. Health J. 9: 61-69.
-
Abdo AA, Bain VG, Kichian K, Lee SS 2002 Evolution of autoimmune hepatitis to primary sclerosing cholangitis: a sequential syndrome.
Hepatology 36: 1393-1399.
*
-
Abe T, Arai T, Ogawa A, Hiromatsu T, Masuda A, Matsuguchi T, Nimura Y, Yoshikai Y 2004 Kupffer cell-derived interleukin 10 is responsible for impaired bacterial clearance in bile duct-ligated mice.
Hepatology 40: 414-423.
*
-
Abenavoli L, De Maria V, DeSiena M, DiSalvo S, Giancotti F, Gravina T, Abenavoli SM 2007 Familial intrahepatic cholestasis. Novel advances.
Recenti Prog. Med. 98: 569-573.
-
Abitbol M, Puy H, Sabate JM, Guenet JL, Deybach JC, Montagutelli X 2007 Ursodeoxycholic acid and heme-arginate are unable to improve hematopoiesis and liver injury in an erythropoietic protoporphyria mouse model.
Physiol. Res. 55 Suppl. 2: S93-S101.
*
-
Aboutwerat A, Pemberton PW, Smith A, Burrows PC, McMahon RF, Jain SK, Warnes TW 2003 Oxidant stress is a significant feature of primary biliary cirrhosis.
Biochim. Biophys. Acta 1637: 142-150.
*
-
Abraham S, Szabo A, Kaszaki J, Varga R, Eder K, Duda E, Lazar G, Tiszlavicz L, Boros M, Lazar G Jr 2008 Kupffer cell blockade improves the endotoxin-induced microcirculatory inflammatory response in obstructive jaundice.
Shock 30: 69-74.
-
Abramowsky C, Dahms B, Swinehart G 1985 IgA-associated glomerular deposits in liver disease.
Hum. Pathol. 16: 1243-1246.
-
Abu-Sa'da O, Barbar M, Al-Harbi N, Taha D 2005 Arthrogryposis, renal tubular acidosis and cholestasis (ARC) syndrome: two new cases and review.
Clin. Dysmorphol. 14: 191-196.
-
Aburano T 1995 Radionuclide imaging in hepatobiliary disease.
Kaku Igaku 32: 599-603.
-
Aburano T, Takayama T, Shuke N, Kinuya S, Tonami N, Hisada K, Hirai N, Tanaka E, Kobayashi K, Hattori N 1987 Hepatobiliary scintigraphy in chronic intrahepatic cholestasis - diagnosis of primary sclerosing cholangitis.
Kaku Igaku 24: 543-550.
-
Accatino L, Contreras A, Berdichevsky E, Quintana C 1981 The effect of complete biliary obstruction on bile secretion. Studies on the mechanisms of postcholestatic choleresis in the rat.
J. Lab. Clin. Med. 97: 525-534.
-
Accatino L, Contreras A, Fernandez S, Quintana C 1979 The effect of complete biliary obstruction on bile flow and bile acid excretion: postcholestatic choleresis in the rat.
J. Lab. Clin. Med. 93: 706-717.
-
Accatino L, Figueroa C, Pizarro M, Solis N 1995 Enhanced biliary excretion of canalicular membrane enzymes in estrogen-induced and obstructive cholestasis, and effects of different bile acids in the isolated perfused rat liver.
J. Hepatol. 22: 658-670.
*
-
Accatino L, Hono J, Koenig C, Pizarro M, Rodriguez L 1993 Adaptive changes of hepatic bile salt transport in a model of reversible interruption of the enterohepatic circulation in the rat.
J. Hepatol. 19: 95-104.
-
Accatino L, Pizarro M, Solis N, Arrese M, Vollrath V, Ananthanarayanan M, Chianale J, Koenig CS 2000 Differential expression of canalicular membrane Ca2+/Mg(2+)-ecto-ATPase in estrogen-induced and obstructive cholestasis in the rat.
J. Lab. Clin. Med. 136: 125-137.
*
-
Accatino L, Pizarro M, Solis N, Koenig CS, Vollrath V, Chianale J 1996 Modulation of hepatic content and biliary excretion of P-glycoproteins in hepatocellular and obstructive cholestasis in the rat.
J. Hepatol. 25: 349-361.
*
-
Actis GC, Fadda M, Pellicano R, David E, Rizzetto M, Sapino A 2008 The 17-year single-center experience with the use of azathioprine to maintain remission in ulcerative colitis.
Biomed. Pharmacother. Jul 9 [Epub ahead of print].
-
Adachi Y, Kamisako T 1996 Intrahepatic cholestasis.
Nippon Rinsho 54: 788-793.
-
Adani GL, Lorenzin D, Curro G, Sainz-Barriga M, Comuzzi C, Bresadola V, Avellini C, Baccarani U 2007 Selective bilirubin removal by plasma treatment with Plasorba BR-350 for early cholestatic graft dysfunction.
Transplant. Proc. 39: 1904-1906.
*
-
Adegbola O, Yang H, Zhuang H 2006 Hepatobiliary scintigraphy monitoring patency of partial external biliary diversion in a patient with progressive familial intrahepatic cholestasis.
Clin. Nucl. Med. 31: 622-623.
-
Adham M, Dumortier J, Abdelaal A, Sagnard P, Boucaud C, Boillot O 2007 Does middle hepatic vein omission in a right split graft affect the outcome of liver transplantation? A comparative study of right split livers with and without the middle hepatic vein.
Liver Transpl. 13: 829-837.
*
-
Adjarov D, Popov S, Ivanov E 1976 Studies on the mechanism of the changes in serum and liver gamma-glutamyl transpeptidase activity. I. Experimental extrahepatic cholestasis in rabbits.
Enzyme 21: 1-7.
-
Adler M, Chung KW, Schaffner F 1980 Pericanalicular hepatocytic and bile ductular microfilaments in cholestasis in man.
Am. J. Pathol. 98: 603-616.
-
Afford SC, Hubscher S, Strain AJ, Adams DH, Neuberger JM 1995 Apoptosis in the human liver during allograft rejection and end-stage liver disease.
J. Pathol. 176: 373-380.
-
Aghai ZH, Mudduluru M, Nakhla TA, Amendolia B, Longo D, Kemble N, Kaki S, Sutsko R, Saslow JG, Stahl GE 2006 Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis.
J. Perinatol. 26: 550-555.
-
Agrons GA, Corse WR, Markowitz RI, Suarez ES, Perry DR 1996 Gastrointestinal manifestations of cystic fibrosis: radiologic-pathologic correlation.
Radiographics 16: 871-893.
*
-
Ai Y, Liu SY, Yao Q 2004 Clinical characteristics of 1241 cases of intrahepatic cholestasis of pregnancy.
Zhonghua Fu Chan Ke Za Zhi 39: 217-220.
-
Aithal PG, Day CP 1999 The natural history of histologically proved drug induced liver disease.
Gut 44: 731-735.
*
-
Akamatsu N, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Togashi J, Makuuchi M 2007 Impact of live donor age (>/=50) on liver transplantation.
Transplant. Proc. 39: 3189-3193.
*
-
Akashi M, Tanaka A, Takikawa H 2006 Effect of cyclosporin A on the biliary excretion of cholephilic compounds in rats.
Hepatol. Res. 34: 193-198.
-
Akobeng AK, Clayton PT, Miller V, Super M, Thomas AG 1999 An inborn error of bile acid synthesis (3beta-hydroxy-delta5-C27-steroid dehydrogenase deficiency) presenting as malabsorption leading to rickets.
Arch. Dis. Child. 80: 463-465.
*
-
Akoume MY, Perwaiz S, Yousef IM, Plaa GL 2003 Synergistic role of 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol 7alpha-hydroxylase in the pathogenesis of manganese-bilirubin-induced cholestasis in rats.
Toxicol. Sci. 73: 378-385.
*
-
Akoume MY, Tuchweber B, Plaa GL, Yousef IM 2004 The role of mdr2 in manganese-bilirubin induced cholestasis in mice.
Toxicol. Lett. 148: 41-51.
*
-
Akwabi-Ameyaw A, Bass JY, Caldwell RD, Caravella JA, Chen L, Creech KL, Deaton DN, Jones SA, Kaldor I, Liu Y, Madauss KP, Marr HB, McFadyen RB, Miller AB, Iii FN, Parks DJ, Spearing PK, Todd D, Williams SP, Wisely GB 2008 Conformationally constrained farnesoid X receptor (FXR) agonists: naphthoic acid-based analogs of GW 4064.
Bioorg. Med. Chem. Lett. 18: 4339-4343.
*
-
Al-Hathlol K, Al-Madani A, Al-Saif S, Abulaimoun B, Al-Tawil K, El-Demerdash A 2006 Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
Singapore Med. J. 47: 147-151.
*
-
Al-Masri AN, Flemming P, Rodeck B, Melter M, Leonhardt J, Petersen C 2006 Expression of the interferon-induced Mx proteins in biliary atresia.
J. Pediatr. Surg. 41: 1139-1143.
-
al-Quaiz MN, O'Grady JG, Tredger JM, Williams R 1994 Variable effect of ursodeoxycholic acid on cyclosporin absorption after orthotopic liver transplantation.
Transpl. Int. 7: 190-194.
-
Alagille D 1985 Management of paucity of interlobular bile ducts.
J. Hepatol. 1: 561-565.
-
Alallam A, Barth D, Heathcote EJ 2008 Role of plasmapheresis in the treatment of severe pruritus in pregnant patients with primary biliary cirrhosis: case reports.
Can. J. Gastroenterol. 22: 505-507.
-
Alam I, Ferrell LD, Bass NM 1996 Vanishing bile duct syndrome temporally associated with ibuprofen use.
Am. J. Gastroenterol. 91: 1626-1630.
-
Alam I, Levenson SD, Ferrell LD, Bass NM 1997 Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis. Case report and review of the literature.
Dig. Dis. Sci. 42: 1295-1301.
*
-
Alazmi WM, Fogel EL, Watkins JL, McHenry L, Tector JA, Fridell J, Mosler P, Sherman S, Lehman GA 2006 Recurrence rate of anastomotic biliary strictures in patients who have had previous successful endoscopic therapy for anastomotic narrowing after orthotopic liver transplantation.
Endoscopy 38: 571-574.
-
Alba LM, Angulo P, Lindor KD 2002 Primary sclerosing cholangitis.
Minerva Gastroenterol. Dietol. 48: 99-113.
-
Alburquerque Miranda M, Vargas Cardenas G, Lozano Miranda Z, Reyes Mugruza T, Li Torres W, Valdivia Roldan M 2008 Recurrent benign intrahepatic cholestasis and their progression to familiar progressive intrahepatic cholestasis.
Rev. Gastroenterol. Peru 28: 183-188.
-
Aleksunes LM, Slitt AL, Maher JM, Dieter MZ, Knight TR, Goedken M, Cherrington NJ, Chan JY, Klaassen CD, Manautou JE 2006 Nuclear factor-E2-related factor 2 expression in liver is critical for induction of NAD(P)H:quinone oxidoreductase 1 during cholestasis.
Cell Stress Chaperones 11: 356-363.
-
Alexander P, Roskams T, Van Steenbergen W, Peetermans W, Desmet V, Yap SH 1991 Intrahepatic cholestasis induced by amoxicillin/clavulanic acid (Augmentin): a report on two cases.
Acta Clin. Belg. 46: 327-332.
-
Alissa FT, Jaffe R, Shneider BL 2008 Update on progressive familial intrahepatic cholestasis.
J. Pediatr. Gastroenterol. Nutr. 46: 241-252.
-
Allocca M, Crosignani A, Gritti A, Benetti A, Zuin M, Podda M, Battezzati PM 2007 Inadequate dietary intake but not renal tubular acidosis is associated with bone demineralization in primary biliary cirrhosis.
Aliment. Pharmacol. Ther. 25: 219-227.
*
-
Allocca M, Crosignani A, Gritti A, Ghilardi G, Gobatti D, Caruso D, Zuin M, Podda M, Battezzati PM 2006 Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis.
Gut 55: 1795-1800.
*
-
Almasio P, Bortolini M, Pagliaro L, Coltorti M 1990 Role of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis.
Drugs 40 Suppl. 3: 111-123.
-
Almasio PL, Floreani A, Chiaramonte M, Provenzano G, Battezzati P, Crosignani A, Podda M, Todros L, Rosina F, Saccoccio G, Manenti F, Ballardini G, Bianchi FP, Scheuer PJ, Davies SE, Craxi A 2000 Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis.
Aliment. Pharmacol. Ther. 14: 1645-1652.
*
-
Alnounou M, Munoz SJ 2006 Nutrition Issues In Gastroenterology, Series #37. Nutrition concerns of the patient with primary biliary cirrhosis or primary sclerosing cholangitis. [http://www.healthsystem.virginia.edu/internet/digestive-health/nutritionarticles/April2006.pdf]
Practical Gastroenterology April 2006: 92-100. *
-
Alonso EM, Snover DC, Montag A, Freese DK, Whitington PF 1994 Histologic pathology of the liver in progressive familial intrahepatic cholestasis.
J. Pediatr. Gastroenterol. Nutr. 18: 128-133.
-
Alpini G, Baiocchi L, Glaser S, Ueno Y, Marzioni M, Francis H, Phinizy JL, Angelico M, Lesage G 2002 Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.
Hepatology 35: 1041-1052.
*
-
Altuncu E, Akman I, Kiyan G, Ersu R, Yurdakul Z, Bilgen H, Ozdogan T, Ozek E 2007 Report of three cases: congenital chylothorax and treatment modalities.
Turk. J. Pediatr. 49: 418-421.
-
Alvarez F, Landrieu P, Laget P, Lemonnier F, Odievre M, Alagille D 1983 Nervous and ocular disorders in children with cholestasis and vitamin A and E deficiencies.
Hepatology 3: 410-414.
-
Alvarez L, Jara P, Hierro L, Sanchez-Sabate E, Martinez-Fernandez P, Lopez-Santamaria M 2005 Molecular basis of cholestatic diseases of surgical interest.
Semin. Pediatr. Surg. 14: 200-205.
-
Alvarez L, Jara P, Sanchez-Sabate E, Hierro L, Larrauri J, Diaz MC, Camarena C, De La Vega A, Frauca E, Lopez-Collazo E, Lapunzina P 2004 Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1.
Hum. Mol. Genet. 13: 2451-2460.
*
-
Alvaro D, Benedetti A, Marucci L, Delle Monache M, Monterubbianesi R, Di Cosimo E, Perego L, Macarri G, Glaser S, Le Sage G, Alpini G 2000 The function of alkaline phosphatase in the liver: regulation of intrahepatic biliary epithelium secretory activities in the rat.
Hepatology 32: 174-184.
*
-
Alvaro D, Gigliozzi A, Piat C, Carli L, Bini A, La Rosa T, Furfaro S, Capocaccia L 1995 Effect of S-adenosyl-L-methionine on ethanol cholestasis and hepatotoxicity in isolated perfused rat liver.
Dig. Dis. Sci. 40: 1592-1600.
-
Alvaro D, Macarri G, Mancino MG, Marzioni M, Bragazzi M, Onori P, Corradini SG, Invernizzi P, Franchitto A, Attili AF, Gaudio E, Benedetti A 2007 Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis.
Ann. Intern. Med. 147: 451-459.
-
Alvaro D, Piat C, Francia C, Franchitto A, Furfaro S, Valente C, Capocaccia L, Gaudio E 1996 Ultrastructural features of danazol-induced cholestasis: a case study.
Ultrastruct. Pathol. 20: 491-495.
-
Ambinder EP, Cohen LB, Wolke AM, Field SP, Adelsberg B, Schaffner F, Zaroulis CG 1985 The clinical effectiveness and safety of chronic plasmapheresis in patients with primary biliary cirrhosis.
J. Clin. Apheresis 2: 219-223.
-
Ambros-Rudolph CM, Glatz M, Trauner M, Kerl H, Mullegger RR 2007 The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from Central Europe.
Arch. Dermatol. 143: 757-762.
*
-
Amedee-Manesme O, Furr HC, Alvarez F, Hadchouel M, Alagille D, Olson JA 1985 Biochemical indicators of vitamin A depletion in children with cholestasis.
Hepatology 5: 1143-1148.
-
Amedee-Manesme O, Mourey MS, Therasse J, Couturier M, Alvarez F, Hanck A, Bernard O 1988 Short- and long-term vitamin A treatment in children with cholestasis.
Am. J. Clin. Nutr. 47: 690-693.
*
-
Amedee-Manesme O, Therasse J, Hadchouel M, Mourey MS, Couturier M, Alagille D 1985 Vitamin A status in liver diseases in children. Study based on 79 hepatic biopsies.
Arch. Fr. Pediatr. 42 Suppl. 1: 591-595.
-
Amer OT, Abd El-Rahma HA, Sherief LM, Hussein HF, Zeid AF, Abd El-Aziz AM 2004 Role of some viral infections in neonatal cholestasis.
Egypt J. Immunol. 11: 149-155.
-
American Gastroenterological Association 2002 American Gastroenterological Association medical position statement: evaluation of liver chemistry tests.
Gastroenterology 123: 1364-1366.
*
-
Ammann R 2006 Diagnosis and management of chronic pancreatitis: current knowledge.
Swiss Med. Wkly. 136: 166-174.
*
-
Anagnostis P, Stangou M, Leontsini M, Athyros VG, Karagiannis A 2008 Unusual manifestation of diarrhea-associated haemolytic uraemic syndrome in an adult.
Ren. Fail. 30: 331-334.
-
Andersen S, Okkels H, Krarup H, Laurberg P 2006 Geographical clustering and maintained health in individuals harbouring the mutation for Greenland familial cholestasis: a population-based study.
Scand. J. Gastroenterol. 41: 445-450.
*
-
Anderson KE, Simionatto CS, Drummond GS, Kappas A 1986 Disposition of tin-protoporphyrin and suppression of hyperbilirubinemia in humans.
Clin. Pharmacol. Ther. 39: 510-520.
-
Ang TL, Teo EK, Fock KM 2007 Endosonography- vs. endoscopic retrograde cholangiopancreatography-based strategies in the evaluation of suspected common bile duct stones in patients with normal transabdominal imaging.
Aliment. Pharmacol. Ther. 26: 1163-1170.
*
-
Angulo P 2002 Use of ursodeoxycholic acid in patients with liver disease.
Curr. Gastroenterol. Rep. 4: 37-44.
-
Angulo P, Maor-Kendler Y, Lindor KD 2002 Small-duct primary sclerosing cholangitis: a long-term follow-up study.
Hepatology 35: 1494-1500.
*
-
Angulo P, Pearce DH, Johnson CD, Henry JJ, LaRusso NF, Petersen BT, Lindor KD 2000 Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis.
J. Hepatol. 33: 520-527.
*
-
Antolic B, Gersak K, Verdenik I, Novak-Antolic Z 2006 Adverse effects of thyroid dysfunction on pregnancy and pregnancy outcome: epidemiologic study in Slovenia.
J. Matern. Fetal Neonatal Med. 19: 651-654.
-
Anwer MS 2004 Cellular regulation of hepatic bile acid transport in health and cholestasis.
Hepatology 39: 581-590.
*
-
Ara C, Esrefoglu M, Polat A, Isik B, Aladag M, Gul M, Ay S, Tekerleklioglu MS, Yilmaz S 2006 The effect of caffeic acid phenethyl ester on bacterial translocation and intestinal damage in cholestatic rats.
Dig. Dis. Sci. 51: 1754-1760.
*
-
Ara C, Kirimlioglu H, Karabulut AB, Coban S, Ay S, Harputluoglu M, Kirimlioglu V, Yilmaz S 2005 Protective effect of resveratrol against oxidative stress in cholestasis.
J. Surg. Res. 127: 112-117.
*
-
Argao EA, Heubi JE 1993 Fat-soluble vitamin deficiency in infants and children.
Curr. Opin. Pediatr. 5: 562-566.
-
Arias IM 2008 Perspective: five decades of cholestasis research and the brave new world.
Hepatology 47: 777-785.
*
-
Arnell H, Bergdahl S, Papadogiannakis N, Nemeth A, Fischler B 2008 Preoperative observations and short-term outcome after partial external biliary diversion in 13 patients with progressive familial intrahepatic cholestasis.
J. Pediatr. Surg. 43: 1312-1320.
-
Arnell H, Nemeth A, Anneren G, Dahl N 1997 Progressive familial intrahepatic cholestasis (PFIC): evidence for genetic heterogeneity by exclusion of linkage to chromosome 18q21-q22.
Hum. Genet. 100: 378-381.
*
-
Arnon R, Yoshimura T, Reiss A, Budai K, Lefkowitch JH, Javitt NB 1998 Cholesterol 7-hydroxylase knockout mouse: a model for monohydroxy bile acid-related neonatal cholestasis.
Gastroenterology 115: 1223-1228.
*
-
Aromataris EC, Castro J, Rychkov GY, Barritt GJ 2008 Store-operated Ca(2+) channels and stromal interaction molecule 1 (STIM1) are targets for the actions of bile acids on liver cells.
Biochim. Biophys. Acta 1783: 874-885.
*
-
Arranz MI, Lasuncion MA, Perales J, Herrera E, Lorenzo I, Carcamo C, Concostrina L, Villar J, Gasalla R 1996 Fatty acid composition of lipoprotein lipids in hepatobiliary diseases.
Eur. J. Clin. Chem. Clin. Biochem. 34: 701-709.
-
Arrese M 2006 Cholestasis during pregnancy: rare hepatic diseases unmasked by pregnancy.
Ann. Hepatol. 5: 216-218.
*
-
Arrese M, Accatino L 1993 Ursodeoxycholic acid in the treatment of cholestatic liver diseases.
Rev. Med. Chil. 121: 439-446.
-
Arrese M, Accatino L 2003 Is intrahepatic cholestasis of pregnancy an MDR3-related disease?
Gastroenterology 125: 1922-1923.
*
-
Arrese M, Ananthananarayanan M, Suchy FJ 1998 Hepatobiliary transport: molecular mechanisms of development and cholestasis.
Pediatr. Res. 44: 141-147.
-
Arrese M, Ananthanarayanan M 2004 The bile salt export pump: molecular properties, function and regulation.
Pflugers Arch. 449: 123-131.
*
-
Arrese M, Macias RI, Briz O, Perez MJ, Marin JJ 2008 Molecular pathogenesis of intrahepatic cholestasis of pregnancy.
Expert Rev. Mol. Med. 10: e9.
-
Arrese M, Pizarro M, Solis N, Koenig C, Accatino L 1995 Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.
Biochem. Pharmacol. 50: 1223-1232.
-
Arrese M, Reyes H 2006 Intrahepatic cholestasis of pregnancy: a past and present riddle.
Ann. Hepatol. 5: 202-205.
*
-
Arrese M, Trauner M 2003 Molecular aspects of bile formation and cholestasis.
Trends Mol. Med. 9: 558-564.
*
-
Arroyo M, Crawford JM 2006 Hepatitic inherited metabolic disorders.
Semin. Diagn. Pathol. 23: 182-189.
-
Arslan N, Mavi A, Kalkan S, Aydin A, Ortac R, Buyukgebiz B, Durak H 2006 Findings of hepatobiliary scintigraphy and liver biopsy in Maroteaux-Lamy syndrome presenting as neonatal cholestasis.
Pediatr. Int. 48: 498-500.
*
-
Arslanoglu S, Moro GE, Tauschel HD, Boehm G 2008 Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition.
J. Pediatr. Gastroenterol. Nutr. 46: 228-231.
-
Arundel C, Lewis JH 2007 Drug-induced liver disease in 2006.
Curr. Opin. Gastroenterol. 23: 244-254.
-
Arvay JL, Zemel BS, Gallagher PR, Rovner AJ, Mulberg AE, Stallings VA, Haber BA 2005 Body composition of children aged 1 to 12 years with biliary atresia or Alagille syndrome.
J. Pediatr. Gastroenterol. Nutr. 40: 146-150.
*
-
Arvieux C, Calmus Y, Gane P, Legendre C, Mariani P, Delelo R, Poupon R, Nordlinger B 1993 Immunogenicity of rat hepatocytes in vivo: effect of cholestasis-induced changes in major histocompatibility complex expression.
J. Hepatol. 18: 335-341.
-
Asatiani G, Tokhadze L, Gopodze L 2006 Oxidative homeostasis of organism during mechanical jaundice.
Georgian Med. News 134: 115-118.
-
Asimuakopoulos G 2006 Pregnancy and liver disease.
Rev. Med. Chir. Soc. Med. Nat. Iasi. 110: 326-333.
-
Asma K, Dalila G, Olfa B, Malika R, Afef K, Najet B, Jamel K, Abdeljabbar G, Sarra S, Chiraz J, Mohamed HD, Slim K, Anis BM, Abdelmajid L 2005 Cholangitis revealing an intrahepatic Osler's disease.
Tunis. Med. 83: 495-498.
-
Aspinall AI, Adams DH 2006 Sickness behaviors in chronic cholestasis: an immune-mediated process?
Hepatology 43: 20-23.
*
-
Aspirot A, Su W, Flageole H, Puligandla PS, Shaw K, Laberge JM 2007 Cholestasis associated with small bowel atresia: do we always need to investigate?
J. Pediatr. Surg. 42: 873-877.
-
Assem M, Schuetz EG, Leggas M, Sun D, Yasuda K, Reid G, Zelcer N, Adachi M, Strom S, Evans RM, Moore DD, Borst P, Schuetz JD 2004 Interactions between hepatic Mrp4 and Sult2A as revealed by the constitutive androstane receptor and Mrp4 knockout mice.
J. Biol. Chem. 279: 22250-22257.
*
-
Assenat E, Gerbal-Chaloin S, Larrey D, Saric J, Fabre JM, Maurel P, Vilarem MJ, Pascussi JM 2004 Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance.
Hepatology 40: 951-960.
*
-
Assimakopoulos SF, Grintzalis K, Thomopoulos KC, Papapostolou I, Georgiou CD, Gogos C, Vagianos CE 2008 Plasma superoxide radical in jaundiced patients and role of xanthine oxidase.
Am. J. Med. Sci. 336: 230-236.
-
Assimakopoulos SF, Mavrakis AG, Grintzalis K, Papapostolou I, Zervoudakis G, Konstantinou D, Chroni E, Vagianos CE, Georgiou C 2008 Superoxide radical formation in diverse organs of rats with experimentally induced obstructive jaundice.
Redox Rep. 13: 179-184.
-
Atabek ME, Pirgon O 2007 Unusual cardiac features in cholestatic hepatitis A in an adolescent: improvement with corticosteroid treatment.
J. Infect. 54: e91-e93.
-
Atabey S, Duvan CI, Eren U, Turhan NO 2007 Intrahepatic cholestasis and eclampsia: a case report.
Hypertens. Pregnancy 26: 363-369.
-
Attie AD, Flowers MT, Flowers JB, Groen AK, Kuipers F, Ntambi JM 2007 Stearoyl-CoA desaturase deficiency, hypercholesterolaemia, cholestasis and diabetes.
Novartis Found. Symp. 286: 47-53.
-
Atucha NM, Iyu D, Alcaraz A, Rosa V, Martinez-Prieto C, Ortiz MC, Rosado JA, Garcia-Estan J 2007 Altered calcium signaling in platelets from bile duct-ligated rats.
Clin. Sci. (Lond.) 112: 167-174.
*
-
Audard V, Grimber G, Elie C, Radenen B, Audebourg A, Letourneur F, Soubrane O, Vacher-Lavenu MC, Perret C, Cavard C, Terris B 2007 Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations.
J. Pathol. 212: 345-352.
*
-
Ausch C, Hochwarter G, Taher M, Holzer B, Rosen HR, Urban M, Sebesta C, Hruby W, Schiessel R 2005 Improving the safety of laparoscopic cholecystectomy: the routine use of preoperative magnetic resonance cholangiography.
Surg. Endosc. 19: 574-580.
*
-
Ayadi-Kaddour A, Saiji E, Ben Slama S, Chelly-Ennaiffer I, Lahmar-Boufaroua A, Goutallier-Ben Fadhel C, Ben Sassi L, Khalfallah MT, Mzabi-Regaya S 2006 Hepatic mesenchymal hamartoma in adulthood: a case report with literature review.
Tunis. Med. 84: 263-265.
-
Aydogdu S, Cakir M, Arikan C, Tumgor G, Yuksekkaya HA, Yilmaz F, Kilic M 2007 Liver transplantation for progressive familial intrahepatic cholestasis: clinical and histopathological findings, outcome and impact on growth.
Pediatr. Transplant. 11: 634-640.
*
-
Aytac S, Kargili A, Turkay C 2006 A prolonged gestational intrahepatic cholestasis: a case report.
Turk. J. Gastroenterol. 17: 206-208.
*
-
Ayuso L, Vila-Carbo JJ, Lluna J, Hernandez E, Marco A 2008 Laparoscopic Kasai portoenterostom: present and future of biliary atresia treatment.
Cir. Pediatr. 21: 23-26.
-
Azer SA 2004 Do recommended textbooks contain adequate information about bile salt transporters for medical students?
Adv. Physiol. Educ. 28: 36-43.
*
-
Azer SA 2005 A multimedia CD-ROM tool to improve student understanding of bile salts and bilirubin metabolism: evaluation of its use in a medical hybrid PBL course.
Adv. Physiol. Educ. 29: 40-50.
*
-
Azer SA, Canfield PJ, Stacey NH 1995 Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid.
J. Gastroenterol. Hepatol. 10: 261-269.
-
Azer SA, Stacey NH 1996 Current concepts of hepatic uptake, intracellular transport and biliary secretion of bile acids: physiological basis and pathophysiological changes in cholestatic liver dysfunction.
J. Gastroenterol. Hepatol. 11: 396-407.
-
Azria D, Duval G, Brage D, Deltour D, Valette M 1982 Primary sclerosing cholangitis. External biliary drainage by the transhepatic percutaneous approach. A case report.
J. Radiol. 63: 359-362.
-
Azzaroli F, Mennone A, Feletti V, Simoni P, Baglivo E, Montagnani M, Rizzo N, Pelusi G, DE Aloysio D, Lodato F, Festi D, Colecchia A, Roda E, Boyer JL, Mazzella G 2007 Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid.
Aliment. Pharmacol. Ther. 26: 1139-1146.
*
-
Babany G, Descatoire V, Corbic M, Gendre S, Degott C, Larrey D, Letteron P, Wandscheer JC, Funck-Brentano C, Pessayre D 1985 Regulation of renal cytochrome P-450. Effects of two-thirds hepatectomy, cholestasis, biliary cirrhosis and post-necrotic cirrhosis on hepatic and renal microsomal enzymes.
Biochem. Pharmacol. 34: 311-320.
-
Babatin MA, Sanai FM, Swain MG 2006 Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
Aliment. Pharmacol. Ther. 24: 813-820.
*
-
Bach N, Thung SN, Schaffner F 1998 The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis.
Arch. Pathol. Lab. Med. 122: 342-345.
-
Bachs L, Pares A, Elena M, Piera C, Rodes J 1989 Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis.
Lancet 1: 574-576.
-
Bachs L, Pares A, Elena M, Piera C, Rodes J 1992 Effects of long-term rifampicin administration in primary biliary cirrhosis.
Gastroenterology 102: 2077-2080.
-
Bacq Y, Myara A, Brechot MC, Hamon C, Studer E, Trivin F, Metman EH 1995 Serum conjugated bile acid profile during intrahepatic cholestasis of pregnancy.
J. Hepatol. 22: 66-70.
*
-
Bahrle S, Szabo G, Stiehl A, Theilmann L, Dengler TJ, Zimmermann R, Kubler W 1998 Adjuvant treatment with ursodeoxycholic acid may reduce the incidence of acute cardiac allograft rejection.
J. Heart Lung Transplant. 17: 592-598.
-
Baiocchi L, Tisone G, Russo MA, Longhi C, Palmieri G, Volpe A, Almerighi C, Telesca C, Carbone M, Toti L, Leonardis FD, Angelico M 2008 TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKCalpha-ezrin pathway.
Transpl. Int. 21: 792-800.
*
-
Baker AL, Krager PS, Kotake AN, Schoeller DA 1987 The aminopyrine breath test does not correlate with histologic disease severity in patients with cholestasis.
Hepatology 7: 464-467.
-
Bako W, Marek A, Sikorska-Wisniewska G, Liberek A, Raczkowska-Kozak J, Gora-Gebka M, Szlagatys-Sidorkiewicz A, Zagierski M, Jankowska A 2006 Short bowel syndrome in children - own experience.
Med. Wieku. Rozwoj. X: 563-572.
-
Bakula A, Socha P, Pawlowska J, Teisseyre M, Jankowska I, Kalicinski P 2007 Good and bad prognosis of alpha-1-antitrypsin deficiency in children: when to list for liver transplantation.
Transplant. Proc. 39: 3186-3188.
*
-
Balistreri WF 1997 Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid.
J. Pediatr. Gastroenterol. Nutr. 24: 573-589.
-
Balistreri WF 2002 Intrahepatic cholestasis.
J. Pediatr. Gastroenterol. Nutr. 35 Suppl. 1: S17-S23.
*
-
Balistreri WF 2003 Genetic liver disease.
54th Annual Meeting of the American Association for the Study of Liver Diseases.
-
Balistreri WF, Bezerra JA 2006 Whatever happened to “neonatal hepatitis”?
Clin. Liver Dis. 10: 27-53.
-
Balistreri WF, Bezerra JA, Jansen P, Karpen SJ, Shneider BL, Suchy FJ 2005 Intrahepatic cholestasis: Summary of an American Association for the Study of Liver Diseases single-topic conference.
Hepatology 42: 222-235.
*
-
Ballonoff A, Kavanagh B, Nash R, Drabkin H, Trotter J, Costa L, Rabinovitch R 2008 Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: statistical analysis of all published cases and literature review.
Acta Oncol. 47: 962-970.
-
Balmer M, Dufour J 2008 Treatment of hypercholesterolemia in patients with primary biliary cirrhosis might be more beneficial than indicated.
Swiss Med. Wkly. 138: 415-419.
*
-
Bambha KM, Biggins SW 2008 Inequities of the model for end-stage liver disease: an examination of current components and future additions.
Curr. Opin. Organ Transplant. 13: 227-233.
-
Ban D, Kudo A, Sui S, Tanaka S, Nakamura N, Ito K, Suematsu M, Arii S 2008 Decreased Mrp2-dependent bile flow in the post-warm ischemic rat liver.
J. Surg. Res. Mar 31 [Epub ahead of print].
-
Bandyopadhyay R, Bandyopadhyay SK, Dutta A 2008 Sickle cell hepatopathy.
Indian J. Pathol. Microbiol. 51: 284-285.
*
-
Bandyopadhyay SK, Bandyopadhyay R, Dutta A 2006 Primary amyloidosis presenting as intrahepatic cholestasis.
Indian J. Pathol. Microbiol. 49: 557-559.
-
Baptista-Gonzalez H, Gutierrez-Landeros F, Rosenfeld-Mann F, Trueba-Gomez R 2004 Changes of coagulation inhibitors and fibrinolysis system in newborn infants with transitory neonatal cholestasis.
Ann. Hepatol. 3: 26-29.
*
-
Barbatis C, Kelly P, Greveson J, Heryet A, McGee JO 1987 Immunocytochemical analysis of HLA class II (DR) antigens in liver disease in man.
J. Clin. Pathol. 40: 879-884.
*
-
Barbero Villares A, Moreno Monteagudo JA, Moreno Borque R, Moreno Otero R 2008 Hepatic involvement in celiac disease.
Gastroenterol. Hepatol. 31: 25-28.
-
Barcena R, Moreno A, Foruny JR, Moreno A, Sanchez J, Gil-Grande L, Blazquez J, Nuno J, Fortun J, Rodriguez-Gandia MA, Oton E 2006 Improved graft function in liver-transplanted patients after partial splenic embolization: reversal of splenic artery steal syndrome?
Clin. Transplant. 20: 517-523.
*
-
Bardia A, Thompson CA, Podratz KC, Okuno SH 2007 Bizarre big belly ball: intraabdominal abscess mimicking Stauffer syndrome secondary to uterine leiomyosarcoma.
Eur. J. Gynaecol. Oncol. 28: 134-136.
-
Barnes DS 2002 Intrahepatic cholestatic liver disease.
http://www.clevelandclinicmeded.com/diseasemanagement/gastro/intrahepatic/intrahepatic1.htm.
-
Barreales M, Perez-Carreras M, Meizoso T, Garrido M, Masedo A, Colina F, Solis JA 2006 Epstein-Barr virus infection and cholestatic hepatitis.
An. Med. Interna. 23: 483-486.
-
Barrio J, Castiella A, Lobo C, Indart A, Lopez P, Garcia-Bengoechea M, Cosme A, Arenas JI 1998 Cholestatic acute hepatitis induced by amoxycillin-clavulanic acid combination. Role of ursodeoxycholic acid in drug-induced cholestasis.
Rev. Esp. Enferm. Dig. 90: 523-526.
-
Barta SK, Yahalom J, Shia J, Hamlin PA 2006 Idiopathic cholestasis as a paraneoplastic phenomenon in Hodgkin's lymphoma.
Clin. Lymphoma Myeloma 7: 77-82.
-
Barth A, Rost M, Kindt A, Peiker G 2005 Serum bile acid profile in women during pregnancy and childbed.
Exp. Clin. Endocrinol. Diabetes 113: 372-375.
-
Bartoli E, Delcenserie R, Yzet T, Brazier F, Geslin G, Regimbeau JM, Dupas JL 2005 Endoscopic treatment of chronic pancreatitis.
Gastroenterol. Clin. Biol. 29: 515-521.
-
Basarir Ozkan T, Mistik R, Dikici B, Ozturk Nazlioglu H 2007 Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis.
BMC Gastroenterol. 7: 9.
*
-
Bass NM, Burroughs AK, Scheuer PJ, James DG, Sherlock S 1982 Chronic intrahepatic cholestasis due to sarcoidosis.
Gut 23: 417-421.
*
-
Bassas A, Chehab M, Hebby H, Al Shahed M, Al Husseini H, Al Zahrani A, Wali S 2003 Living related liver transplantation in 13 cases of progressive familial intrahepatic cholestasis.
Transplant. Proc. 35: 3003-3005.
*
-
Bassendine MF 2004 Infectious etiology of primary biliary cirrhosis (PBC).
Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 45-46. *
-
Bataller R, Brenner DA 2001 Hepatic stellate cells as a target for the treatment of liver fibrosis.
Semin. Liver Dis. 21: 437-451.
-
Battezzati PM, Podda M, Bianchi FB, Naccarato R, Orlandi F, Surrenti C, Pagliaro L, Manenti F 1993 Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBC.
J. Hepatol. 17: 332-338.
-
Battochio AP, Coelho KL, Sartori MS, Coelho CA 2008 Hepatoprotective effect of water soluble extract of Coleus barbatus on cholestasis on young rats.
Acta Cir. Bras. 23: 220-229.
*
-
Battochio AP, Sartori MS, Coelho CA 2005 Water-soluble extract of Coleus barbatus modulates weight gain, energy utilization and lipid metabolism in secondary biliary cirrhosis: an experimental study in young rats.
Acta Cir. Bras. 20: 229-236.
-
Baumbartel E 1977 Cholestasis in ulcerative colitis, case presentation, surgery.
Gastroenterology 73: 368.
-
Beau P, Labat-Labourdette J, Ingrand P, Beauchant M 1994 Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease?
J. Hepatol. 20: 240-244.
-
Beaussier M, Schiffer E, Housset C 2008 Ischaemic cholestasis in intensive care unit.
Ann. Fr. Anesth. Reanim. Aug 28 [Epub ahead of print].
-
Beaussier M, Wendum D, Fouassier L, Rey C, Barbu V, Lasnier E, Lienhart A, Scoazec JY, Rosmorduc O, Housset C 2005 Adaptative bile duct proliferative response in experimental bile duct ischemia.
J. Hepatol. 42: 257-265.
*
-
Bechmann LP, Hilgard P, Frilling A, Schumacher B, Baba HA, Gerken G, Zoepf T 2008 Successful photodynamic therapy for biliary papillomatosis: a case report.
World J. Gastroenterol. 14: 4234-4237.
*
-
Becker M, von Bergmann K, Rotthauwe HW, Leiss O 1984 Biliary lipid metabolism in children with chronic intrahepatic cholestasis.
Eur. J. Pediatr. 143: 35-40.
-
Becker P, Maurer B, Schirmacher P, Waldherr R, Parlesak A, Bode C, Seitz HK 2007 Vitamin A-induced cholestatic hepatitis: a case report.
Z. Gastroenterol. 45: 1063-1066.
-
Becker S, Reinehr R, Graf D, Vom Dahl S, Haussinger D 2007 Hydrophobic bile salts induce hepatocyte shrinkage via NADPH oxidase activation.
Cell. Physiol. Biochem. 19: 89-98.
-
Beilke LD, Besselsen DG, Cheng Q, Kulkarni S, Slitt AL, Cherrington NJ 2008 Minimal role of hepatic transporters in the hepatoprotection against LCA-induced intrahepatic cholestasis.
Toxicol. Sci. 102: 196-204.
*
-
Belinsky MG, Dawson PA, Shchaveleva I, Bain LJ, Wang R, Ling V, Chen ZS, Grinberg A, Westphal H, Klein-Szanto A, Lerro A, Kruh GD 2005 Analysis of the in vivo functions of Mrp3.
Mol. Pharmacol. 68: 160-168.
*
-
Bellentani S, Podda M, Tiribelli C, Callea F, Marazzi M, Sodde M, Merlini R, Batezzati PM, Crosignani A, Zuin M, et al 1993 Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trial.
J. Hepatol. 19: 459-464.
-
Belli DC, Fournier LA, Lepage G, Yousef I, Roy CC 1994 S-Adenosylmethionine prevents total parenteral nutrition-induced cholestasis in the rat.
J. Hepatol. 21: 18-23.
-
Bellomo-Brandao MA, Porta G, Hessel G 2008 Clinical and laboratory evaluation of 101 patients with intrahepatic neonatal cholestasis.
Arq. Gastroenterol. 45: 152-155.
*
-
Ben-Ari Z, Weiss-Schmilovitz H, Sulkes J, Brown M, Bar-Nathan N, Shaharabani E, Yussim A, Shapira Z, Tur-Kaspa R, Mor E 2004 Serum cholestasis markers as predictors of early outcome after liver transplantation.
Clin. Transplant. 18: 130-136.
-
Benedicto I, Molina-Jimenez F, Barreiro O, Maldonado-Rodríguez A, Prieto J, Moreno-Otero R, Aldabe R, Lopez-Cabrera M, Majano PL 2008 Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum.
Hepatology Sep 18 [Epub ahead of print].
-
Benhamla T, Tirouche YD, Abaoub-Germain A, Theodore F 2007 The onset of psychiatric disorders and Wilson's disease.
Encephale 33: 924-932.
-
Benhamou JP 2000 Primary sclerosing cholangitis.
Rev. Prat. 50: 2146-2149.
-
Benninger J, Grobholz R, Oeztuerk Y, Antoni CH, Hahn EG, Singer MV, Strauss R 2005 Sclerosing cholangitis following severe trauma: description of a remarkable disease entity with emphasis on possible pathophysiologic mechanisms.
World J. Gastroenterol. 11: 4199-4205.
*
-
Benninger J, Schneider HT, Schuppan D, Kirchner T, Hahn EG 1999 Acute hepatitis induced by greater celandine (Chelidonium majus).
Gastroenterology 117: 1234-1237.
*
-
Benz C, Angermuller S, Kloters-Plachky P, Sauer P, Stremmel W, Stiehl A 1998 Effect of S-adenosylmethionine versus tauroursodeoxycholic acid on bile acid-induced apoptosis and cytolysis in rat hepatocytes.
Eur. J. Clin. Invest. 28: 577-583.
-
Benz C, Angermuller S, Tox U, Kloters-Plachky P, Riedel HD, Sauer P, Stremmel W, Stiehl A 1998 Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes.
J. Hepatol. 28: 99-106.
*
-
Berenson MM, Welch V, Garcia-Marin JJ 1991 Importance of bile acid structure in amelioration of griseofulvin-induced murine protoporphyric hepatopathy.
J. Lab. Clin. Med. 118: 89-98.
-
Bergasa NV 2004 Treatment of the pruritus of cholestasis.
Curr. Treat. Options Gastroenterol. 7: 501-508.
-
Bergasa NV 2004 Pruritus in chronic liver disease: mechanisms and treatment.
Curr. Gastroenterol. Rep. 6: 10-16.
-
Bergasa NV 2005 The pruritus of cholestasis.
J. Hepatol. 43: 1078-1088.
*
-
Bergasa NV 1995 The pruritus of cholestasis.
Semin. Dermatol. 14: 302-312.
-
Bergasa NV 2003 Management of complications of cholestasis: pruritus, fatigue and bone disease.
Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 54. October 15-16. *
-
Bergasa NV 2004 An approach to the management of the pruritus of cholestasis.
Clin. Liver Dis. 8: 55-66.
-
Bergasa NV 2003 Pruritus and fatigue in primary biliary cirrhosis.
Clin. Liver Dis. 7: 879-900.
-
Bergasa NV 2004 Treatment of the pruritus of cholestasis: from unbearable lightness to substance.
Hepatology 39: 1450-1453.
*
-
Bergasa NV 2008 Pruritus in primary biliary cirrhosis: pathogenesis and therapy.
Clin. Liver Dis. 12: 385-406.
-
Bergasa NV 2008 Update on the treatment of the pruritus of cholestasis.
Clin. Liver Dis. 12: 219-234.
-
Bergasa NV, Alling DW, Talbot TL, Swain MG, Yurdaydin C, Turner ML, Schmitt JM, Walker EC, Jones EA 1995 Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial.
Ann. Intern. Med. 123: 161-167.
-
Bergasa NV, Alling DW, Talbot TL, Wells MC, Jones EA 1999 Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study.
J. Am. Acad. Dermatol. 41: 431-434.
-
Bergasa NV, Boyella VD 2008 Liver derived endogenous opioids may interfere with the therapeutic effect of interferon in chronic hepatitis C.
Med. Hypotheses 70: 556-559.
-
Bergasa NV, Jones EA 1995 The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids.
Gastroenterology 108: 1582-1588.
*
-
Bergasa NV, Jones EA 1998 The pruritus of cholestasis: evolving pathogenic concepts suggest new therapeutic options.
Clin. Liver Dis. 2: 391-405, x.
-
Bergasa NV, Liau S, Homel P, Ghali V 2002 Hepatic Met-enkephalin immunoreactivity is enhanced in primary biliary cirrhosis.
Liver 22: 107-113.
-
Bergasa NV, Link MJ, Keogh M, Yaroslavsky G, Rosenthal RN, McGee M 2001 Pilot study of bright-light therapy reflected toward the eyes for the pruritus of chronic liver disease.
Am. J. Gastroenterol. 96: 1563-1570.
*
-
Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, Worman HJ 2004 Primary biliary cirrhosis: report of a focus study group.
Hepatology 40: 1013-1020.
*
-
Bergasa NV, McGee M, Ginsburg IH, Engler D 2006 Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial.
Hepatology 44: 1317-1323.
*
-
Bergasa NV, Mehlman JK, Jones EA 2000 Pruritus and fatigue in primary biliary cirrhosis.
Baillieres Best Pract. Res. Clin. Gastroenterol. 14: 643-655.
-
Bergasa NV, Schmitt JM, Talbot TL, Alling DW, Swain MG, Turner ML, Jenkins JB, Jones EA 1998 Open-label trial of oral nalmefene therapy for the pruritus of cholestasis.
Hepatology 27: 679-684.
*
-
Bergasa NV, Talbot TL, Alling DW, Schmitt JM, Walker EC, Baker BL, Korenman JC, Park Y, Hoofnagle JH, Jones EA 1992 A controlled trial of naloxone infusions for the pruritus of chronic cholestasis.
Gastroenterology 102: 544-549.
-
Bergheim I, Guo L, Davis MA, Duveau I, Arteel GE 2006 Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis.
J. Pharmacol. Exp. Ther. 316: 592-600.
*
-
Berkane N, Cocheton JJ, Brehier D, Merviel P, Wolf C, Lefevre G, Uzan S 2000 Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. A retrospective study of 19 cases.
Acta Obstet. Gynecol. Scand. 79: 941-946.
-
Berkley EM, Leslie KK, Arora S, Qualls C, Dunkelberg JC 2008 Chronic hepatitis C in pregnancy.
Obstet. Gynecol. 112: 304-310.
-
Bernt C, Vennegeerts T, Beuers U, Rust C 2006 The human transcription factor AP-1 is a mediator of bile acid-induced liver cell apoptosis.
Biochem. Biophys. Res. Commun. 340: 800-806.
*
-
Bernuau J 2003 Hepatic complications of pregnancy.
Rev. Prat. 53: 1889-1893.
-
Berr F 2004 Photodynamic therapy for cholangiocarcinoma.
Semin. Liver Dis. 24: 177-187.
-
Berry PA, Cross TJ, Thein SL, Portmann BC, Wendon JA, Karani JB, Heneghan MA, Bomford A 2007 Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment.
Clin. Gastroenterol. Hepatol. 5: 1469-1476.
-
Berti S, Amato L, Chiarini C, Fabbri P 2005 Case study: an itching and excoriated dermatosis during intrahepatic cholestasis of pregnancy.
Skinmed. 4: 248-249.
-
Bertola G, Balza G, Oriani A, Morganti D, Sironi C, Bonizzato S 2004 Elevated concentration of serum carcinoembryonic antigen in hypothyroidism.
Recenti Prog. Med. 95: 204-206.
-
Bertolotti M, Ferrari A, Vitale G, Stefani M, Trenti T, Loria P, Carubbi F, Carulli N, Sternieri E 1997 Effect of liver cirrhosis on the systemic availability of naltrexone in humans.
J. Hepatol. 27: 505-511.
*
-
Beuers U 2003 Mechanisms of action of ursodeoxycholic acid in cholestasis.
Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 49-50. October 15-16. *
-
Beuers U 2006 Mechanisms of action of ursodeoxycholic acid for treatment of primary sclerosing cholangitis.
Falk Workshop "Primary Sclerosing Cholangitis: Complications and Consequences", Moscow (Russia), June 11, 2006, p. 12. *
-
Beuers U 2006 Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 318-328.
*
-
Beuers U, Bilzer M, Chittattu A, Kullak-Ublick GA, Keppler D, Paumgartner G, Dombrowski F 2001 Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver.
Hepatology 33: 1206-1216.
*
-
Beuers U, Boyer JL, Paumgartner G 1998 Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications.
Hepatology 28: 1449-1453.
*
-
Beuers U, Denk GU, Soroka CJ, Wimmer R, Rust C, Paumgartner G, Boyer JL 2003 Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets.
J. Biol. Chem. 278: 17810-17818.
*
-
Beuers U, Hohenester S, Pusl T, Rust C, Wimmer R 2006 Tauroursodeoxycholic acid antagonizes taurolithocholic acid induced cholestasis via a cooperative protein kinase C- and protein kinase A-dependent signaling pathway in the perfused rat liver.
Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 81. *
-
Beuers U, Hohenester S, Wimmer R, Denk GU, Rust C 2004 Mitogen activated protein kinases and protein kinase C: short-term mediators of the anticholestatic effect of tauroursodeoxycholic acid in bile acid-induced cholestasis?
Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 61. June 18-19. *
-
Beuers U, Oswald M 1998 Cholestasis: therapeutic options.
Ther. Umsch. 55: 97-103.
-
Beuers U, Pusl T 2006 Intrahepatic cholestasis of pregnancy - a heterogeneous group of pregnancy-related disorders?
Hepatology 43: 647-649.
*
-
Beuers U, Spengler U, Sackmann M, Paumgartner G, Sauerbruch T 1992 Deterioration of cholestasis after endoscopic retrograde cholangiography in advanced primary sclerosing cholangitis.
J. Hepatol. 15: 140-143.
-
Bezerra JA 2005 Potential etiologies of biliary atresia.
Pediatr. Transplant. 9: 646-651.
-
Bezerra JA 2006 The next challenge in pediatric cholestasis: deciphering the pathogenesis of biliary atresia.
J. Pediatr. Gastroenterol. Nutr. 43: S23-S29.
*
-
Bhalla S, Ozalp C, Fang S, Xiang L, Kemper JK 2004 Ligand-activated PXR interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha: functional implications in hepatic cholesterol and glucose metabolism.
J. Biol. Chem. 279: 45139-45147.
*
-
Bianchi L, Terracciano LM 1994 Giant cell hepatitis in adults.
Schweiz. Rundsch. Med. Prax. 83: 1237-1241.
-
Biecker E, Sauerbruch T 2006 Control of infection in gastrointestinal endoscopy.
Dtsch. Med. Wochenschr. 131: 2726-2732.
-
Biesiada L, Pietrzak Z, Brocka U, Oszukowski P, Krasomski G 2007 Markers of oxidative stress in pregnancies complicated by pregnancy induced hypertension and intrahepatic cholestasis.
Ginekol. Pol. 78: 956-960.
-
Bihl F, Emmenegger U, Reichen J, Neftel KA, Zimmermann A, Cerny A 2006 Macrophage activating syndrome is associated with lobular hepatitis and severe bile duct injury with cholestasis.
J. Hepatol. 44: 1208-1212.
*
-
Bilezikci B, Demirhan B, Kocbiyik A, Arat Z, Haberal M 2008 Relevant histopathologic findings that distinguish acute cellular rejection from cholangitis in hepatic allograft biopsy specimens.
Transplant. Proc. 40: 248-250.
*
-
Binder G, Martin DD, Kanther I, Schwarze CP, Ranke MB 2007 The course of neonatal cholestasis in congenital combined pituitary hormone deficiency.
J. Pediatr. Endocrinol. Metab. 20: 695-702.
-
Binder T, Salaj P, Zima T 2007 Intrahepatic cholestasis in pregnancy - guidelines of treatment.
Ceska. Gynekol. 72: 94-98.
-
Binder T, Salaj P, Zima T, Vitek L 2006 Ursodeoxycholic acid, S-adenosyl-L-methionine and their combinations in the treatment of gestational intrahepatic cholestasis (ICP).
Ceska. Gynekol. 71: 92-98.
-
Binder T, Salaj P, Zima T, Vitek L 2006 Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy.
J. Perinat. Med. 34: 383-391.
-
Binder T, Zima T, Vítek L 2007 Biochemical parameters of the intrahepatic cholestasis of pregnancy.
Ceska. Gynekol. 72: 90-94.
-
Bjornsson E, Chapman RW 2003 Sclerosing cholangitis.
Curr. Opin. Gastroenterol. 19: 270-275.
-
Bjornsson E, Lindqvist-Ottosson J, Asztely M, Olsson R 2004 Dominant strictures in patients with primary sclerosing cholangitis.
Am. J. Gastroenterol. 99: 502-508.
*
-
Bjornsson ES, Kilander AF, Olsson RG 2000 Bile duct bacterial isolates in primary sclerosing cholangitis and certain other forms of cholestasis - a study of bile cultures from ERCP.
Hepatogastroenterology 47: 1504-1508.
-
Black DD 2005 Chronic cholestasis and dyslipidemia: what is the cardiovascular risk?
J. Pediatr. 146: 306-307.
-
Black M 2003 Drug hepatotoxicity.
Clin. Liver Dis. 7: xi-xii. *
-
Blann AD, Babbs C, Neuberger JM 1992 Endothelial cell damage in primary biliary cirrhosis: influence of cholestasis and immunological mechanisms.
Clin. Exp. Immunol. 90: 88-92.
*
-
Blaszyk H, Wild PJ, Oliveira A, Kelly DG, Burgart LJ 2005 Hepatic copper in patients receiving long-term total parenteral nutrition.
J. Clin. Gastroenterol. 39: 318-320.
-
Blau J, Sridhar S, Mathieson S, Chawla A 2007 Effects of protein/nonprotein caloric intake on parenteral nutrition associated cholestasis in premature infants weighing 600-1000 grams.
JPEN J. Parenter. Enteral Nutr. 31: 487-490.
-
Blich M, Edoute Y 2004 Clinical manifestations of sarcoid liver disease.
J. Gastroenterol. Hepatol. 19: 732-737.
*
-
Bloomer JR, Boyer JL 1975 Phenobarbital effects in cholestatic liver diseases.
Ann. Intern. Med. 82: 310-317.
-
Boberg KM, Schrumpf E 2004 Diagnosis and treatment of cholangiocarcinoma.
Curr. Gastroenterol. Rep. 6: 52-59.
-
Boberg KM, Schrumpf E 1997 Treatment of cholestatic liver diseases with ursodeoxycholic acid.
Tidsskr. Nor. Laegeforen. 117: 3370-3373.
-
Bochkis IM, Rubins NE, White P, Furth EE, Friedman JR, Kaestner KH 2008 Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress.
Nat. Med. 14: 828-836.
*
-
Bodin K, Lindbom U, Diczfalusy U 2005 Novel pathways of bile acid metabolism involving CYP3A4.
Biochim. Biophys. Acta 1687: 84-93.
*
-
Boelsterli UA, Rakhit G, Balazs T 1983 Modulation by S-adenosyl-L-methionine of hepatic Na+,K+-ATPase, membrane fluidity, and bile flow in rats with ethinyl estradiol-induced cholestasis.
Hepatology 3: 12-17.
-
Bogdanos D, Vergani D, Mieli-Vergani G 2004 Overlap syndromes from pediatrics to adulthood.
J. Gastroenterol. Hepatol. 19: S284-S286. *
-
Bogdanos DP, Baum H, Gunsar F, Arioli D, Polymeros D, Ma Y, Burroughs AK, Vergani D 2004 Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity.
Scand. J. Gastroenterol. 39: 981-987.
*
-
Bogdanovic M, Bulat P 2008 Biliary function in workers occupationally exposed to aluminium dust and fumes.
Arh. Hig. Rada. Toksikol. 59: 135-139.
-
Bogert PT, LaRusso NF 2007 Cholangiocyte biology.
Curr. Opin. Gastroenterol. 23: 299-305.
-
Bohan A, Boyer JL 2002 Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions.
Semin. Liver Dis. 22: 123-136.
-
Bohan A, Chen WS, Denson LA, Held MA, Boyer JL 2003 Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis.
J. Biol. Chem. 278: 36688-36698.
*
-
Bohme M, Jedlitschky G, Leier I, Buchler M, Keppler D 1994 ATP-dependent export pumps and their inhibition by cyclosporins.
Adv. Enzyme Regul. 34: 371-380.
-
Bohme M, Muller M, Leier I, Jedlitschky G, Keppler D 1994 Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver.
Gastroenterology 107: 255-265.
-
Bolder U, Thasler WE, Hofmann AF, Jauch KW 1998 Hepatocellular transport of bile acids and organic anions in infection and SIRS - evidence for different mechanisms for regulating membrane transport proteins.
Langenbecks Arch. Chir. Suppl. Kongressbd. 115 (Suppl. I): 391-396.
-
Bolder U, Ton-Nu HT, Schteingart CD, Frick E, Hofmann AF 1997 Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion.
Gastroenterology 112: 214-225.
*
-
Bolder U, Trang NV, Hagey LR, Schteingart CD, Ton-Nu HT, Cerre C, Elferink RP, Hofmann AF 1999 Sulindac is excreted into bile by a canalicular bile salt pump and undergoes a cholehepatic circulation in rats.
Gastroenterology 117: 962-971.
*
-
Bolt MJ, Sitrin MD, Favus MJ, Rosenberg IH 1981 Hepatic vitamin D 25-hydroxylase: inhibition by bile duct ligation or bile salts.
Hepatology 1: 436-440.
-
Bolukbas C, Bolukbas FF, Horoz M, Baba ZF, Eser M, Uzunkoy A, Ucar E, Kaya Z, Guran S 2005 Magnetic resonance cholangiopancreatography in cholestatic diseases.
Hepatogastroenterology 52: 705-708.
-
Boner AL, Peroni D, Bodini A, Delaini G, Piacentini G 2007 Azithromycin may reduce cholestasis in primary sclerosing cholangitis: a case report and serendipitous observation.
Int. J. Immunopathol. Pharmacol. 20: 847-849.
-
Bonin S, Pascolo L, Croce LS, Stanta G, Tiribelli C 2002 Gene expression of ABC proteins in hepatocellular carcinoma, perineoplastic tissue, and liver diseases.
Mol. Med. 8: 318-325.
-
Boone RH, Cheung AM, Girlan LM, Heathcote EJ 2006 Osteoporosis in primary biliary cirrhosis: a randomized trial of the efficacy and feasibility of estrogen/progestin.
Dig. Dis. Sci. 51: 1103-1112.
*
-
Borgia G, Crowell J, Ciampi R, Nappa S, Lambiase A, Piazza M 1984 Unusual ultrastructural findings in a case of asymptomatic primary biliary cirrhosis.
Boll. Soc. Ital. Biol. Sper. 60: 249-255.
-
Bories C, Certin M, Lavergne A, Galian A, Godeau P, Rambaud JC 1984 Primary biliary cirrhosis and sarcoidosis. Association or unique disease?
Gastroenterol. Clin. Biol. 8: 851-855.
-
Bos AP, Tibboel D, Hazebroek FW, Bergmeijer JH, van Kalsbeek EJ, Molenaar JC 1990 Total parenteral nutrition associated cholestasis: a predisposing factor for sepsis in surgical neonates?
Eur. J. Pediatr. 149: 351-353.
-
Bosman C, Renda F, Boldrini R, Bosman C 1994 Intrahepatic cholestasis by paucity of interlobular bile ducts in infancy.
Recenti Prog. Med. 85: 375-383.
-
Boucherie S, Koukoui O, Nicolas V, Combettes L 2005 Cholestatic bile acids inhibit gap junction permeability in rat hepatocyte couplets and normal rat cholangiocytes.
J. Hepatol. 42: 244-251
(2005).
*
-
Boulton-Jones JR, Fenn RM, West J, Logan RF, Ryder SD 2004 Fracture risk of women with primary biliary cirrhosis: no increase compared with general population controls.
Aliment. Pharmacol. Ther. 20: 551-557.
*
-
Bourke B, Goggin N, Walsh D, Kennedy S, Setchell KD, Drumm B 1996 Byler-like familial cholestasis in an extended kindred.
Arch. Dis. Child. 75: 223-227.
-
Bouyahia O, Khelifi I, Mazigh SM, Gharsallah L, Chaouachi B, Hamzaoui M, Barsaoui S, Ben Becher S, Bousnina S, Boukthir S, El Gharbi AS 2008 Cholestasis in infant: a study of the children's Hospital of Tunis.
Tunis. Med. 86: 128-135.
-
Bove KE, Heubi JE, Balistreri WF, Setchell KD 2004 Bile acid synthetic defects and liver disease: a comprehensive review.
Pediatr. Dev. Pathol. 7: 315-334.
*
-
Bower RH 1983 Hepatic complications of parenteral nutrition.
Semin. Liver Dis. 3: 216-224.
-
Boyer JL 2007 New perspectives for the treatment of cholestasis: lessons from basic science applied clinically.
J. Hepatol. 46: 365-371.
*
-
Boyer JL 2005 Nuclear receptor ligands: rational and effective therapy for chronic cholestatic liver disease?
Gastroenterology 129: 735-740.
*
-
Boyer JL, Denk G, Bohan A, Chen WS, Soroka C, Denson L 2004 Adaptive regulation of bile salt transporters in cholestasis.
Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 46-47. June 18-19. *
-
Boyer JL, Trauner M, Mennone A, Soroka CJ, Cai SY, Moustafa T, Zollner G, Lee JY, Ballatori N 2006 Up-regulation of a basolateral FXR-dependent bile acid efflux transporter, OSTalpha-OSTbeta, in cholestasis in humans and rodents.
Am. J. Physiol. Gastrointest. Liver Physiol. 290: G1124-G1130.
*
-
Brahm J, Chesta J 1993 Bacteriuria in patients with primary biliary cirrhosis.
Rev. Med. Chil. 121: 499-502.
-
Braier J, Ciocca M, Latella A, de Davila MG, Drajer M, Imventarza O 2002 Cholestasis, sclerosing cholangitis, and liver transplantation in Langerhans cell histiocytosis.
Med. Pediatr. Oncol. 38: 178-182.
*
-
Brailski Kh, Chernev K, Pomakov P, Bozhianov V 1982 Percutaneous transhepatic cholangiography with an ultra-fine needle (Chiba) in the diagnosis and differential diagnosis of cholestasis.
Vutr. Boles. 21: 29-36.
-
Brailski Kh, Damianov B 1983 Primary biliary cirrhosis.
Vutr. Boles. 22: 27-37.
-
Bralet MP, Zafrani ES 1996 Hepatitis caused by the amoxicillin-clavulanic acid combination. An example of drug-induced biliary hepatotoxicity.
Ann. Pathol. 16: 425-429.
-
Bramkamp M, Dedes KJ, Strobel K, Pahnke J, Breitenstein S, Clavien PA 2007 Cholestasis from malignant melanoma.
J. Clin. Oncol. 25: 725-726.
*
-
Brandoni A, Anzai N, Kanai Y, Endou H, Torres AM 2006 Renal elimination of p-aminohippurate (PAH) in response to three days of biliary obstruction in the rat. The role of OAT1 and OAT3.
Biochim. Biophys. Acta 1762: 673-682.
*
-
Brandoni A, Villar SR, Picena JC, Anzai N, Endou H, Torres AM 2006 Expression of rat renal cortical OAT1 and OAT3 in response to acute biliary obstruction.
Hepatology 43: 1092-1100.
*
-
Bravo I, Amigo L, Cohen DE, Nervi F, Rigotti A, Francone O, Zanlungo S 2007 Role of plasma and liver cholesterol- and lipoprotein-metabolism determinants in LpX formation in the mouse.
Biochim. Biophys. Acta 1770: 979-988.
*
-
Bremmelgaard A, Alme B 1980 Analysis of plasma bile acid profiles in patients with liver diseases associated with cholestasis.
Scand. J. Gastroenterol. 15: 593-600.
-
Bremmelgaard A, Sjovall J 1980 Hydroxylation of cholic, chenodeoxycholic, and deoxycholic acids in patients with intrahepatic cholestasis.
J. Lipid Res. 21: 1072-1081.
*
-
Brenard R, Dumortier P, Del Natale M, Honhon B, Van Den Berghe M, Bataille C, Rickaert F, Henrion J, Peny MO, Rahier J 2007 Black pigments in the liver related to gold and titanium deposits. A report of four cases.
Liver Int. 27: 408-413.
*
-
Breuer A, Benz SR, Enz T, Deubler G, Mork H 2007 Autoimmune pancreatitis - a rare and difficult differential diagnosis to pancreatic cancer.
Med. Klin. (Munich) 102: 157-162.
-
Brites D 2002 Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.
Ann. Hepatol. 1: 20-28.
*
-
Brites D, Rodrigues CM 1998 Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy.
J. Hepatol. 29: 743-751.
*
-
Brites D, Rodrigues CM, Oliveira N, Cardoso M, Graca LM 1998 Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.
J. Hepatol. 28: 91-98.
*
-
Briz O, Romero MR, Martinez-Becerra P, Macias RI, Perez MJ, Jimenez F, San Martin FG, Marin JJ 2006 OATP8/1B3-mediated cotransport of bile acids and glutathione: an export pathway for organic anions from hepatocytes?
J. Biol. Chem. 281: 30326-30335.
*
-
Brocklehurst D, Wilde CE, Doar JW 1978 The incidence and likely origins of serum particulate alkaline phosphatase and lipoprotein-X in liver disease.
Clin. Chim. Acta 88: 509-515.
-
Brodanova M 2003 Cholestasis.
Vnitr. Lek. 49: 689-695.
-
Broome U 2005 Clinical concepts in PSC.
Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 76. *
-
Brown AP, Dunstan RW, Courtney CL, Criswell KA, Graziano MJ 2008 Cutaneous lesions in the rat following administration of an irreversible inhibitor of erbB receptors, including the epidermal growth factor receptor.
Toxicol. Pathol. 36: 410-419.
-
Bruce K, Watson S 2007 Management of intrahepatic cholestasis of pregnancy: a case report.
J. Midwifery Womens Health 52: 67-72.
-
Bruguera M, Barrera J, Corradi F, Mas A 2005 Hypertransaminasemia greater than 400 U/l in adults attended.
Gastroenterol. Hepatol. 28: 15-19.
-
Bruguera M, Llach J, Rodes J 1992 Nonsyndromic paucity of intrahepatic bile ducts in infancy and idiopathic ductopenia in adulthood: the same syndrome?
Hepatology 15: 830-834.
-
Brunner W 1995 Pruritus - also a challenge in internal medicine.
Schweiz. Med. Wochenschr. 125: 2244-2250.
-
Btaiche IF, Khalidi N 2002 Parenteral nutrition-associated liver complications in children.
Pharmacotherapy 22: 188-211.
-
Buckley SE, DiPalma JA 1996 Recognizing primary biliary cirrhosis and primary sclerosing cholangitis.
Am. Fam. Physician 53: 195-200.
-
Budillon G 1993 The epidemiology of cholestasis in hepatopathies.
Ann. Ital. Med. Int. 8: 36S-40S.
-
Bueno MR, Daneri A, Armendariz-Borunda J 2000 Cholestasis-induced fibrosis is reduced by interferon alpha-2a and is associated with elevated liver metalloprotease activity.
J. Hepatol. 33: 915-925.
*
-
Bueverov AO 2004 Treatment of autoimmune hepatic diseases.
Klin. Med. (Mosk.) 82: 62-66.
-
Bugeac N, Pacht A, Mandel H, Iancu T, Tamir A, Srugo I, Shaoul R 2007 The significance of isolated elevation of serum aminotransferases in infants and young children.
Arch. Dis. Child. 92: 1109-1112.
-
Buis CI, Hoekstra H, Verdonk RC, Porte RJ 2006 Causes and consequences of ischemic-type biliary lesions after liver transplantation.
J. Hepatobiliary Pancreat. Surg. 13: 517-524.
*
-
Bull LN, Carlton VE, Stricker NL, Baharloo S, DeYoung JA, Freimer NB, Magid MS, Kahn E, Markowitz J, DiCarlo FJ, McLoughlin L, Boyle JT, Dahms BB, Faught PR, Fitzgerald JF, Piccoli DA, Witzleben CL, O'Connell NC, Setchell KD, Agostini RM Jr, et al 1997 Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity.
Hepatology 26: 155-164.
*
-
Bull LN, Juijn JA, Liao M, van Eijk MJ, Sinke RJ, Stricker NL, DeYoung JA, Carlton VE, Baharloo S, Klomp LW, Abukawa D, Barton DE, Bass NM, Bourke B, Drumm B, Jankowska I, Lovisetto P, McQuaid S, Pawlowska J, Tazawa Y, Villa E, Tygstrup N, Berger R, et al 1999 Fine-resolution mapping by haplotype evaluation: the examples of PFIC1 and BRIC.
Hum. Genet. 104: 241-248.
*
-
Bull LN, van Eijk MJ, Pawlikowska L, DeYoung JA, Juijn JA, Liao M, Klomp LW, Lomri N, Berger R, Scharschmidt BF, Knisely AS, Houwen RH, Freimer NB 1998 A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis.
Nat. Genet. 18: 219-224.
*
-
Bulle F, Mavier P, Zafrani ES, Preaux AM, Lescs MC, Siegrist S, Dhumeaux D, Guellaen G 1990 Mechanism of gamma-glutamyl transpeptidase release in serum during intrahepatic and extrahepatic cholestasis in the rat: a histochemical, biochemical and molecular approach.
Hepatology 11: 545-550.
-
Burdelski M, Rogiers X 1999 Liver transplantation in metabolic disorders.
Acta Gastroenterol. Belg. 62: 300-305.
-
Burkard I, von Eckardstein A, Rentsch KM 2005 Differentiated quantification of human bile acids in serum by high-performance liquid chromatography-tandem mass spectrometry.
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 826: 147-159.
*
-
Burnstein AV, Galambos JT 1981 [14C]Aminopyrine breath test in chronic liver disease: preliminary diagnostic implications.
Dig. Dis. Sci. 26: 1078-1083.
-
Burrows RF, Clavisi O, Burrows E 2001 Interventions for treating cholestasis in pregnancy.
Cochrane Database Syst. Rev. 4: CD000493.
*
-
Burt AD 2004 Spectrum of liver pathology in immune mediated liver diseases.
J. Gastroenterol. Hepatol. 19: S353-S355. *
-
Burt AD 2002 Primary biliary cirrhosis and other ductopenic diseases.
Clin. Liver Dis. 6: 363-380.
-
Buscher HP, Miltenberger C, MacNelly S, Gerok W 1989 The histoautoradiographic localization of taurocholate in rat liver after bile duct ligation. Evidence for ongoing secretion and reabsorption processes.
J. Hepatol. 8: 181-191.
-
Bush A, Mitchison H, Walt R, Baron JH, Boylston AW, Summerfield JA 1987 Primary biliary cirrhosis and ulcerative colitis.
Gastroenterology 92: 2009-2013.
-
Bustorff-Silva J, Neto LS, Olimpio H, de Alcantara RV, Matsushima E, De Tommaso AM, Brandao MA, Hessel G 2007 Partial internal biliary diversion through a cholecystojejunocolonic anastomosis-a novel surgical approach for patients with progressive familial intrahepatic cholestasis: a preliminary report.
J. Pediatr. Surg. 42: 1337-1340.
-
Busuttil Naudi A, Ammari AB, Fung DE 2008 A report of 2 cases of green pigmentation in the primary dentition associated with cholestasis caused by sepsis.
J. Dent. Child. (Chic.) 75: 91-94.
-
Buts JP, De Keyser N, Collette E, Bonsignore M, Lambotte L, Desjeux JF, Sokal EM 1996 Intestinal transport of calcium in rat biliary cirrhosis.
Pediatr. Res. 40: 533-541.
-
Butscheid M, Hauptvogel P, Fritz P, Klotz U, Alscher D 2007 Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease.
J. Clin. Pathol. 60: 415-418.
-
Byl B, Deviere J, Struelens MJ, Roucloux I, De Coninck A, Thys JP, Cremer M 1995 Antibiotic prophylaxis for infectious complications after therapeutic endoscopic retrograde cholangiopancreatography: a randomized, double-blind, placebo-controlled study.
Clin. Infect. Dis. 20: 1236-1240.
-
Byrne JA, Meara NJ, Rayner AC, Thompson RJ, Knisely AS 2007 Lack of hepatocellular CD10 along bile canaliculi is physiologic in early childhood and persistent in Alagille syndrome.
Lab. Invest. 87: 1138-1148.
*
-
Byrne JA, Strautnieks SS, Ihrke G, Knisely AS, Jirsa M, Cebecauerova D, Linton KJ, Higgins CF, Mieli-Vergani G, Thompson RJ 2006 Investigation of the disease mechanisms associated with missense mutations in the bile salt export pump, BSEP.
Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 61. *
-
Byrne JA, Strautnieks SS, Mieli-Vergani G, Higgins CF, Linton KJ, Thompson RJ 2002 The human bile salt export pump: characterization of substrate specificity and identification of inhibitors.
Gastroenterology 123: 1649-1658.
*
-
Caballeria L, Pares A, Rodes J 1999 Treatment of primary biliary cirrhosis.
Contributions to Science 1: 79-85. *
-
Cabrera-Abreu JC, Green A 2002 Gamma-glutamyltransferase: value of its measurement in paediatrics.
Ann. Clin. Biochem. 39: 22-25.
-
Cai W, Wu J, Hong L, Xu Y, Tang Q, Shi C 2006 Oxidative injury and hepatocyte apoptosis in total parenteral nutrition-associated liver dysfunction.
J. Pediatr. Surg. 41: 1663-1668.
-
Calamita G, Ferri D, Gena P, Carreras FI, Liquori GE, Portincasa P, Marinelli RA, Svelto M 2008 Altered expression and distribution of aquaporin-9 in the liver of rat with obstructive extrahepatic cholestasis.
Am. J. Physiol. Gastrointest. Liver Physiol. Jul 31 [Epub ahead of print].
*
-
Calmelet P, Coumaros D, Viville B, Raiga J, Favreau JJ, Treisser A 1998 Ursodeoxycholic acid: prospect for treatment of gravidic cholestasis? Report of 3 cases.
J. Gynecol. Obstet. Biol. Reprod. (Paris) 27: 617-621.
-
Calmus Y, Arvieux C, Gane P, Boucher E, Nordlinger B, Rouger P, Poupon R 1992 Cholestasis induces major histocompatibility complex class I expression in hepatocytes.
Gastroenterology 102: 1371-1377.
-
Calmus Y, Guechot J, Podevin P, Bonnefis MT, Giboudeau J, Poupon R 1992 Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-alpha production by monocytes.
Hepatology 16: 719-723.
-
Calmus Y, Poupon R 1991 Ursodeoxycholic acid (UDCA) in the treatment of chronic cholestatic diseases.
Biochimie 73: 1335-1338.
-
Calmus Y, Weill B, Ozier Y, Chereau C, Houssin D, Poupon R 1992 Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse.
Gastroenterology 103: 617-621.
-
Camara B, Kamar N, Bonafe JL, Danjoux M, Suc B, Rostaing L 2007 Syphilis hepatitis and liver transplantation.
Med. Mal. Infect. 37: 121-123.
-
Camara B, Kamar N, Bonafe JL, Danjoux M, Suc B, Rostaing L 2007 Syphilis-related hepatitis in a liver transplant patient.
Exp. Clin. Transplant. 5: 724-726.
-
Cameron RG, Blendis LM, Neuman MG 2001 Accumulation of macrophages in primary sclerosing cholangitis.
Clin. Biochem. 34: 195-201.
*
-
Canbay A, Guicciardi ME, Higuchi H, Feldstein A, Bronk SF, Rydzewski R, Taniai M, Gores GJ 2003 Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis.
J. Clin. Invest. 112: 152-159.
*
-
Cancado EL, Leitao RM, Carrilho FJ, Laudanna AA 1998 Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gamma-glutamyl transpeptidase.
Am. J. Gastroenterol. 93: 1510-1517.
*
-
Candela G, Varriale S, Napolitano S, Di Libero L, Manetta F, Sciascia V, Giordano M, Maschio A, Santini L 2007 Diagnosis and treatment of gallbladder and common bile duct stones: our experience.
Minerva. Chir. 62: 167-172.
-
Canovic P, Gajovic O, Todorovic Z, Mijailovic Z 2006 Epstein-Barr virus hepatitis associated with icterus - a case report.
Med. Pregl. 59: 179-182.
-
Cantu P, Hookey LC, Morales A, Le Moine O, Deviere J 2005 The treatment of patients with symptomatic common bile duct stenosis secondary to chronic pancreatitis using partially covered metal stents: a pilot study.
Endoscopy 37: 735-739.
-
Capitanich P, Herrera J, Iovaldi ML, Balbuena R, Casas G, Malizia P, Bun M, Mezzadri N 2005 Bile duct replacement using an autologous femoral vein graft: an experimental study. Preliminary results.
J. Gastrointest. Surg. 9: 369-373.
-
Cappell MS 2008 Hepatic disorders severely affected by pregnancy: medical and obstetric management.
Med. Clin. North Am. 92: 739-760.
-
Capron JP, Degott C, Bernuau J, Saint-Marc Girardin MF, Zafrani ES, Braillon A, Quenum C, Dhumeaux D, Benhamou JP 1983 Nodular regenerative hyperplasia of the liver. Study of 15 cases and review of the literature.
Gastroenterol. Clin. Biol. 7: 761-769.
-
Capron JP, Sevenet F, Quenum C, Doutrellot C, Capron-Chivrac D, Delamarre J 1983 Massive hepatic steatosis disclosing adult celiac disease. Study of a case and review of the literature.
Gastroenterol. Clin. Biol. 7: 256-260.
-
Carcagni MR, De Aloe G, D'Ascenzo G, Rubegni P, Fimiani M 2008 Extracorporeal photopheresis in graft-versus-host disease.
J. Dtsch. Dermatol. Ges. 6: 451-457.
-
Cardona J, Houssin D, Gauthier F, Devictor D, Losay J, Hadchouel M, Bernard O 1995 Liver transplantation in children with Alagille syndrome - a study of twelve cases.
Transplantation 60: 339-342.
-
Carlton VE, Knisely AS, Freimer NB 1995 Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis region.
Hum. Mol. Genet. 4: 1049-1053.
-
Carlton VE, Pawlikowska L, Bull LN 2004 Molecular basis of intrahepatic cholestasis.
Ann. Med. 36: 606-617.
-
Carrella M, Roda E 1999 Evolving concepts in the pathophysiology of biliary lipid secretion.
Ital. J. Gastroenterol. Hepatol. 31: 643-648.
-
Carreras F, Lehmann GL, Ferri D, Tioni MF, Calamita G, Marinelli RA 2007 Defective hepatocyte aquaporin-8 expression and educed canalicular membrane water permeability in estrogen-induced cholestasis.
Am. J. Physiol. Gastrointest. Liver Physiol. 292: G905-G912.
*
-
Carter BA, Prendergast DR, Taylor OA, Zimmerman TL, Furstenberg RV, Moore DD, Karpen SJ 2007 Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR.
Pediatr. Res. 62: 301-306.
-
Carter BA, Shulman RJ 2007 Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis.
Nat. Clin. Pract. Gastroenterol. Hepatol. 4: 277-287.
*
-
Castell JV, Castell M 2006 Allergic hepatitis induced by drugs.
Curr. Opin. Allergy Clin. Immunol. 6: 258-265.
-
Castillo-Gomez E, Colomina-Rodriguez J, Gimeno-Vilarrasa F, Moll-Navarro MJ, Guerrero-Espejo A. 2007 Marked hypertransaminasemia incidence in a health department in the autonomous community of Valencia, Spain (2002-2003).
Rev. Esp. Salud. Publica. 81: 271-278.
-
Castro E Silva O, Sankarankutty AK, Martinelli AL, Souza FF, Teixeira AC, Feres O, Mente ED, Oliveira GR, Akita R, Muglia V, Elias J Jr, Ramalho LN, Zucoloto S 2006 Therapeutic effect of hyperbaric oxygen in hepatic artery thrombosis and functional cholestasis after orthotopic liver transplantation.
Transplant. Proc. 38: 1913-1917.
*
-
Castro-e-Silva Junior O, Franco CF, Souza ME, Picinato MA, Santos JS, Ceneviva R 1990 Serum gamma-glutamyl transpeptidase in chronic extrahepatic cholestasis.
Braz. J. Med. Biol. Res. 23: 515-518.
-
Cathebras PJ, Mosnier JF, Gouilloud S, Bouchou K, Rousset H 1995 Hepatic granulomatosis in a patient with Graves' disease.
Eur. J. Gastroenterol. Hepatol. 7: 905-908.
-
Caughey AB 2006 Cholestasis of pregnancy: in need of a more rapid diagnosis.
J. Perinatol. 26: 525-526.
*
-
Cavestro GM, Frulloni L, Cerati E, Ribeiro LA, Corrente V, Sianesi M, Franze A, Di Mario F 2002 Progressive familial intrahepatic cholestasis.
Acta Biomed. Ateneo. Parmense. 73: 53-56.
-
Cederblad G, Korsan-Bengtsen K, Olsson R 1976 Observations of increased levels of blood coagulation factors and other plasma proteins in cholestatic liver disease.
Scand. J. Gastroenterol. 11: 391-396.
-
Celik T, Goren MZ, Cinar K, Gurdal H, Onder FO, Tan A, Terzioglu B, Bozdayi AM, Bozkaya H, Uzunalimoglu O, Yurdaydin C 2005 Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat.
Hepatology 41: 731-737.
*
-
Cello JP 1977 Cholestasis in ulcerative colitis. Case presentation, postoperative course.
Gastroenterology 73: 368.
-
Chaabouni M, Bahloul S, Ben Romdhane W, Ben Saleh M, Ben Halima N, Chouchene C, Ben Hmad A, Zroud N, Kammoun T, Karray A 2007 Epidemiological, etiological and evolutionary aspects of children cirrhosis in a developing country: experience of the pediatric department of SFAX University hospital, Tunisia.
Tunis. Med. 85: 738-743.
-
Chamouard P, Walter P, Baumann R, Poupon R 2005 Prolonged cholestasis associated with short-term use of celecoxib.
Gastroenterol. Clin. Biol. 29: 1286-1288.
-
Chamuleau RA, Diekman MJ, Bos PJ, Smitt JH, Bosma A, Schellekens PT 1992 Reappearance of vanished bile ducts.
Hepatogastroenterology 39: 523-524.
-
Chan RY, Tan CE, Czech-Schmidt G, Petersen C 2005 Computerized three-dimensional study of a rotavirus model of biliary atresia: comparison with human biliary atresia.
Pediatr. Surg. Int. 21: 615-620.
*
-
Chand N, Sanyal AJ 2007 Sepsis-induced cholestasis.
Hepatology 45: 230-241.
*
-
Chandra P, Brouwer KL 2004 The complexities of hepatic drug transport: current knowledge and emerging concepts.
Pharm. Res. 21: 719-735.
*
-
Chang SW, Ohara N 1992 Pulmonary circulatory dysfunction in rats with biliary cirrhosis. An animal model of the hepatopulmonary syndrome.
Am. Rev. Respir. Dis. 145: 798-805.
-
Chang Y, Golkar L 2008 The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case.
Pediatr. Dermatol. 25: 403-404.
-
Chapman RW 2003 The management of primary sclerosing cholangitis.
Curr. Gastroenterol. Rep. 5: 9-17.
-
Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, Sherlock S 1980 Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology.
Gut 21: 870-877.
*
-
Chatzipantelis P, Lazaris AC, Kafiri G, Papadimitriou K, Papathomas TG, Nonni A, Patsouris ES 2006 Cytokeratin-7, cytokeratin-19, and c-Kit: immunoreaction during the evolution stages of primary biliary cirrhosis.
Hepatol. Res. 36: 182-187.
-
Chauvel O, Lacombe K, Bonnard P, Lascoux-Combe C, Molina JM, Miailhes P, Girard PM, Carrat F 2007 Risk factors for acute liver enzyme abnormalities in HIV-hepatitis B virus-coinfected patients on antiretroviral therapy.
Antivir. Ther. 12: 1115-1126.
-
Chawla A, Kahn E, Yunis EJ, Daum F 2000 Rapidly progressive cholestasis: an unusual reaction to amoxicillin/clavulanic acid therapy in a child.
J. Pediatr. 136: 121-123.
*
-
Chawla RK, Bonkovsky HL, Galambos JT 1990 Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease.
Drugs 40 Suppl. 3: 98-110.
-
Chazouilleres O 1999 Chronic cholestatic disorders in the adult.
Pathol. Biol. (Paris) 47: 974-982.
-
Chazouilleres O, Marteau P, Haniche M, Jian R, Poupon R 1996 Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA).
Dig. Dis. Sci. 41: 2417-2422.
-
Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R 1998 Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.
Hepatology 28: 296-301.
*
-
Chen CY, Tsai WL, Wu HC, Syu MJ, Wu CC, Shiesh SC 2008 Diagnostic role of biliary pancreatic elastase for cholangiocarcinoma in patients with cholestasis.
Clin. Chim. Acta 390: 82-89.
*
-
Chen CY, Tsao PN, Chen HL, Chou HC, Hsieh WS, Chang MH 2004 Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis.
J. Pediatr. 145: 317-321.
*
-
Chen F, Ananthanarayanan M, Emre S, Neimark E, Bull LN, Knisely As A, Strautnieks SS, Thompson RJ, Magid MS, Gordon R, Balasubramanian N, Suchy FJ, Shneider BL 2004 Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity.
Gastroenterology 126: 756-764.
*
-
Chen HL 2006 Sonographic diagnosis in infantile cholestasis.
Acta Paediatr. Taiwan 47: 167-168.
-
Chen HL, Chang PS, Hsu HC, Lee JH, Ni YH, Hsu HY, Jeng YM, Chang MH 2001 Progressive familial intrahepatic cholestasis with high gamma-glutamyltranspeptidase levels in Taiwanese infants: role of MDR3 gene defect?
Pediatr. Res. 50: 50-55.
*
-
Chen HL, Liu YJ, Chen HL, Wu SH, Ni YH, Ho MC, Lai HS, Hsu WM, Tseng HC, Jeng YM, Chang MH 2008 Expression of hepatocyte transporters and nuclear receptors in children with early and late-stage biliary atresia.
Pediatr. Res. 63: 667-673.
-
Chen HL, Liu YJ, Su YN, Wang NY, Wu SH, Ni YH, Hsu HY, Wu TC, Chang MH 2008 Diagnosis of BSEP/ABCB11 mutations in Asian patients with cholestasis using denaturing high performance liquid chromatography.
J. Pediatr. Aug 8 [Epub ahead of print].
*
-
Chen HL, Wang R, Chen HL, Hwu WL, Jeng YM, Chang MH, Ling V 2008 Bone marrow transplantation results in donor-derived hepatocytes in an animal model of inherited cholestatic liver disease.
J. Biomed. Sci. May 29 [Epub ahead of print].
*
-
Chen HW, Chen HL, Ni YH, Lee NC, Chien YH, Hwu WL, Huang YT, Chiu PC, Chang MH 2008 Chubby face and the biochemical parameters for the early diagnosis of neonatal intrahepatic cholestasis caused by citrin deficiency.
J. Pediatr. Gastroenterol. Nutr. 47: 187-192.
-
Chen J, Ahmad J 2008 Cefdinir-induced hepatotoxicity: potential hazards of inappropriate antibiotic use.
J. Gen. Intern. Med. Aug 28 [Epub ahead of print].
-
Chen J, Raymond K 2006 Nuclear receptors, bile-acid detoxification, and cholestasis.
Lancet 367: 454-456.
*
-
Chen J, Raymond K 2006 Treatment effect of rifampicin on cholestasis.
The Internet Journal of Pharmacology Vol. 4 (http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijpharm/vol4n2/colestasis.xml).
-
Chen J, Terada T, Ogasawara K, Katsura T, Inui KI 2008 Adaptive responses of renal organic anion transporter 3 (OAT3) during cholestasis.
Am. J. Physiol. Renal Physiol. 295: F247-F252.
*
-
Chen W, Cai SY, Xu S, Denson L, Soroka C, Boyer JL 2007 Nuclear receptors RXRalpha:RARalpha are repressors for human MRP3 expression.
Am. J. Physiol. Gastrointest. Liver Physiol. 292: G1221-G1227.
*
-
Chen W, Gluud C 2004 Bile acids for liver transplanted patients.
Cochrane Database Syst. Rev. 2: CD004384. *
-
Chen YC, Huang LT, Wang SM, Tiao MM, Liu JW 2007 Acute hepatitis A infection in children: a 20-year experience of a medical center in Southern Taiwan.
Acta Paediatr. Taiwan 48: 131-134.
-
Chen YH, Hong IC, Kuo KK, Hsu HK, Hsu C 2007 Role of retinoid-X receptor-alpha in the suppression of rat bile acid coenzyme A-amino acid N-acyl transferase in liver during sepsis.
Shock 28: 65-70.
-
Chen ZQ, Annilo T, Shulenin S, Dean M 2004 Three ATP-binding cassette transporter genes, Abca14, Abca15, and Abca16, form a cluster on mouse chromosome 7F3.
Mamm. Genome 15: 335-343.
*
-
Cheng JB, Jacquemin E, Gerhardt M, Nazer H, Cresteil D, Heubi JE, Setchell KD, Russell DW 2003 Molecular genetics of 3beta-hydroxy-Delta5-C27-steroid oxidoreductase deficiency in 16 patients with loss of bile acid synthesis and liver disease.
J. Clin. Endocrinol. Metab. 88: 1833-1841.
*
-
Cherrington NJ, Slitt AL, Li N, Klaassen CD 2004 Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats.
Drug Metab. Dispos. 32: 734-741.
*
-
Cherry K 2005 Ursodeoxycholic acid for treatment of intrahepatic cholestasis of pregnancy.
Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 555.
*
-
Chevailler A, Saint-Andre JP, Preel JL, Boyer J, Joubaud F, Hurez D 1988 Clinico-immunological profile of hepatic and extrahepatic diseases accompanied by anti-mitochondrial antibodies.
Ann. Med. Interne. (Paris) 139: 19-23.
-
Chhetri D, Gupta R, Duseja A, Dhiman RK, Chawla Y, Das A 2007 Benign recurrent intrahepatic cholestasis (BRIC) in an adult.
Trop. Gastroenterol. 28: 186-187.
-
Chiarla C, Giovannini I, Siegel JH 2008 Patterns of correlation of plasma ceruloplasmin in sepsis.
J. Surg. Res. 144: 107-110.
-
Chien RN, Sheen IS, Chen TJ, Liaw YF 1992 A clinicopathological study in primary biliary cirrhosis.
J. Formos. Med. Assoc. 91 Suppl. 2: S117-S121.
-
Chitturi S, Farrell GC 2001 Drug-induced cholestasis.
Semin. Gastrointest. Dis. 12: 113-124.
-
Chitturi S, Farrell GC 2000 Drug-induced liver disease.
Curr. Treat. Options Gastroenterol. 3: 457-462.
-
Cho JY, Suh KS, Lee HW, Cho EH, Yang SH, Cho YB, Yi NJ, Kim MA, Jang JJ, Lee KU 2006 Hepatic steatosis is associated with intrahepatic cholestasis and transient hyperbilirubinemia during regeneration after living donor liver transplantation.
Transpl. Int. 19: 807-813.
*
-
Cho JY, Suh KS, Lee HW, Cho EH, Yang SH, Cho YB, Yi NJ, Kim MA, Jang JJ, Lee KU 2006 Hypoattenuation in unenhanced CT reflects histological graft dysfunction and predicts 1-year mortality after living donor liver transplantation.
Liver Transpl. 12: 1403-1411.
*
-
Cho YJ, Han DS, Kim TY, Jang SJ, Jeon YC, Sohn JH, Lee IH, Park KN 1999 Negative conversion of antimitochondrial antibody in primary biliary cirrhosis: a case of autoimmune cholangitis.
J. Korean Med. Sci. 14: 102-106.
-
Choi J, Park JK, Lee KT, Park KK, Kim WB, Lee JH, Jung HJ, Park HJ 2005 In vivo antihepatotoxic effects of Ligularia fischeri var. spiciformis and the identification of the active component, 3,4-dicaffeoylquinic acid.
J. Med. Food 8: 348-352.
-
Chounta A, Zouridakis S, Ellinas C, Tsiodras S, Zoumpouli C, Kopanakis S, Giamarellou H 2005 Cholestatic liver injury after glimepiride therapy.
J. Hepatol. 42: 944-946.
*
-
Chow KM, Chan YY, Choi PC, Szeto CC 2007 Cholestasis in an elderly patient with pneumonia.
Intern. Med. J. 37: 832-833.
*
-
Christen H, Bau J, Halsband H 1975 Hereditary alpha1-antitrypsin deficiency associated with congenital extrahepatic bile duct hypoplasia.
Klin. Wochenschr. 53: 90-91.
-
Christensen E 2004 Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC): which treatments are of value?
[http://www.easl.ch/PGC/Erik%20Christensen.pdf]. *
-
Christensen E, Altman DG, Neuberger J, De Stavola BL, Tygstrup N, Williams R 1993 Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups.
Gastroenterology 105: 1865-1876.
-
Christensen E, Crowe J, Doniach D, Popper H, Ranek L, Rodes J, Tygstrup N, Williams R 1980 Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients.
Gastroenterology 78: 236-246.
-
Christensen E, Neuberger J, Crowe J, Altman DG, Popper H, Portmann B, Doniach D, Ranek L, Tygstrup N, Williams R 1985 Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial.
Gastroenterology 89: 1084-1091.
-
Christensen KL, Andersen BN, Vilstrup H 1997 Primary sclerosing cholangitis with itching treated during pregnancy with ursodeoxycholic acid.
Ugeskr. Laeger. 159: 7151-7153.
-
Chung KW, Han NI, Choi SW, Ahn BM, Yoon SK, Nam SW, Lee YS, Han JY, Sun HS 2002 Increased microfilaments in hepatocytes and biliary ductular cells in cholestatic liver diseases.
J. Korean Med. Sci. 17: 795-800.
-
Cicek D, Kandi B, Demir B, Turgut D 2007 Intrahepatic cholestasis occurring with prurigo of pregnancy.
Skinmed. 6: 298-301.
-
Cies JJ, Giamalis JN 2007 Treatment of cholestatic pruritus in children.
Am. J. Health Syst. Pharm. 64: 1157-1162.
*
-
Cijevschi C, Mihai C, Zbranca E, Gogalniceanu P 2005 Osteoporosis in liver cirrhosis.
Rom. J. Gastroenterol. 14: 337-341.
*
-
Cincu RN, Rodriguez-Ortigosa CM, Vesperinas I, Quiroga J, Prieto J 1997 S-Adenosyl-L-methionine protects the liver against the cholestatic, cytotoxic, and vasoactive effects of leukotriene D4: a study with isolated and perfused rat liver.
Hepatology 26: 330-335.
*
-
Cindoruk M, Kerem M, Karakan T, Salman B, Akin O, Alper M, Erdem O, Unal S 2007 Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study.
BMC Gastroenterol. 7: 44.
*
-
Claudel T, Sturm E, Duez H, Torra IP, Sirvent A, Kosykh V, Fruchart JC, Dallongeville J, Hum DW, Kuipers F, Staels B 2002 Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.
J. Clin. Invest. 109: 961-971.
*
-
Claudel T, Sturm E, Kuipers F, Staels B 2004 The farnesoid X receptor: a novel drug target?
Expert Opin. Investig. Drugs 13: 1135-1148.
-
Clavien PA, Sharara AI, Camargo CA Jr, Harland RC, Fitz JG 1996 Evidence that ursodeoxycholic acid prevents steroid-resistant rejection in adult liver transplantation.
Clin. Transplant. 10: 658-662.
-
Clayton PT 2006 Hereditary liver diseases: screening strategies.
Falk Symposium 156. XIII Falk Liver Week (Part II). GENETICS IN LIVER DISEASES, Freiburg (Germany), October 8-9, 2006, p. 42-43. *
-
Clayton PT, Mills KA, Johnson AW, Barabino A, Marazzi MG 1996 Delta 4-3-oxosteroid 5 beta-reductase deficiency: failure of ursodeoxycholic acid treatment and response to chenodeoxycholic acid plus cholic acid.
Gut 38: 623-628.
*
-
Clements D, Rhodes JM, Elias E 1986 Severe bile duct lesions without biochemical evidence of cholestasis in a case of sclerosing cholangitis.
J. Hepatol. 3: 72-74.
-
Clerici C, Castellani D, Asciutti S, Pellicciari R, Setchell KD, O'connell NC, Sadeghpour B, Camaioni E, Fiorucci S, Renga B, Nardi E, Sabatino G, Clementi M, Giuliano V, Baldoni M, Orlandi S, Mazzocchi A, Morelli A, Morelli O 2006 3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.
Toxicol. Appl. Pharmacol. 214: 199-208.
*
-
Coenen C, Wegener M, Wedmann B 1993 Severe backache in clinically inactive ulcerative colitis.
Fortschr. Med. 111: 476-478.
-
Cohen C, Olsen MM 1981 Pediatric total parenteral nutrition. Liver histopathology.
Arch. Pathol. Lab. Med. 105: 152-156.
-
Cohen LB, Ambinder EP, Wolke AM, Field SP, Schaffner F 1985 Role of plasmapheresis in primary biliary cirrhosis.
Gut 26: 291-294.
*
-
Cohran VC, Heubi JE 2003 Treatment of pediatric cholestatic liver disease.
Curr. Treat. Options Gastroenterol. 6: 403-415.
-
Colle I, Van Vlierberghe H, Pattyn P, Troisi R, Vogelaers D, de Hemptinne B, De Vos M 2003 Cholestasis as presenting symptom of portal cavernoma.
Hepatol. Res. 25: 32-37.
*
-
Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C 2000 Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children.
JPEN J. Parenter. Enteral Nutr. 24: 345-350.
-
Colombato LA, Alvarez F, Cote J, Huet PM 1994 Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis?
Gastroenterology 107: 1839-1843.
-
Colombo C 2006 Liver disease in cystic fibrosis.
Falk Symposium 156. XIII Falk Liver Week (Part II). GENETICS IN LIVER DISEASES, Freiburg (Germany), October 8-9, 2006, p. 31-33. *
-
Colombo C, Apostolo MG, Assaisso M, Roman B, Bottani P 1992 Liver disease in cystic fibrosis.
Neth. J. Med. 41: 119-122.
-
Colombo C, Crosignani A, Apostolo MG, Marzano MT, Bettinardi N, Giunta A 1994 Oral bile acids in cystic fibrosis-associated liver disease.
J. R. Soc. Med. 87 Suppl. 21: 20-24.
*
-
Colombo C, Okolicsanyi L, Strazzabosco M 2000 Advances in familial and congenital cholestatic diseases. Clinical and diagnostic implications.
Dig. Liver Dis. 32: 152-159.
-
Colovic R, Micev M, Markovic J, Zogovic S, Colovic N, Stojkovic M 2002 Adenomyoma of the common hepatic duct.
HPB (Oxford) 4: 187-190.
*
-
Coltorti M, Bortolini M, Di Padova C 1990 A review of the studies on the clinical use of S-adenosylmethionine (SAMe) for the symptomatic treatment of intrahepatic cholestasis.
Methods Find. Exp. Clin. Pharmacol. 12: 69-78.
-
Combes B 1997 Ursodeoxycholic acid in primary biliary cirrhosis.
Semin. Liver Dis. 17: 125-128.
-
Combes B, Luketic VA, Peters MG, Zetterman RK, Garcia-Tsao G, Munoz SJ, Lin D, Flye N, Carithers RL Jr 2004 Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis.
Am. J. Gastroenterol. 99: 264-268.
*
-
Conzo G, Amato G, Angrisani L, Bardi U, Belli G, Brancaccio U, Calise F, Celsi S, Corcione F, Cuccurullo D, De Falco G, De Werra C, De Sena G, Docimo G, Esposito MG, Fantini C, Giardiello C, Livrea A, Lorenzo M, Molino C, Musella M, Muto C, et al 2007 Hepaticojejunostomy in the treatment of iatrogenic biliary lesions following laparoscopic cholecystectomy. A retrospective study on 51 cases.
Hepatogastroenterology 54: 2328-2332.
-
Cooper A, Betts JM, Pereira GR, Ziegler MM 1984 Taurine deficiency in the severe hepatic dysfunction complicating total parenteral nutrition.
J. Pediatr. Surg. 19: 462-466.
-
Copaci I, Micu L, Iliescu L, Voiculescu M 2005 New therapeutical indications of ursodeoxycholic acid.
Rom. J. Gastroenterol. 14: 259-266.
*
-
Corbani A, Burroughs AK 2008 Intrahepatic cholestasis after liver transplantation.
Clin. Liver Dis. 12: 111-129.
-
Corpechot C, Ping C, Wendum D, Matsuda F, Barbu V, Poupon R 2006 Identification of a novel 974C-->G nonsense mutation of the MRP2/ABCC2 gene in a patient with Dubin-Johnson syndrome and analysis of the effects of rifampicin and ursodeoxycholic acid on serum bilirubin and bile acids.
Am. J. Gastroenterol. 101: 2427-2432.
*
-
Costa DB, Miksad RA, Buff MS, Wang Y, Dezube BJ 2006 Case of fatal sickle cell intrahepatic cholestasis despite use of exchange transfusion in an African-American patient.
J. Natl. Med. Assoc. 98: 1183-1187.
-
Cravetto C, Molino G, Biondi AM, Cavanna A, Avagnina P, Frediani S 1985 Evaluation of the diagnostic value of serum bile acid in the detection and functional assessment of liver diseases.
Ann. Clin. Biochem. 22: 596-605.
-
Crespo Perez L, Moreira Vicente V, Manzano Fernandez R, Garcia Aguilera XA 2008 Cholestasis associated with pregabalin treatment.
Med. Clin. (Barc.) 130: 157-158.
-
Crippa G, Cagnoni C, Castelli A, Concesi C, Girometta S, Pancotti D, Sverzellati E, Tacchini G, Pierfranceschi MG, Carrara GC 1995 Prolonged treatment with ursodeoxycholic acid for primary biliary cirrhosis.
Clin. Ter. 146: 367-372.
-
Crippin JS, Jorgensen RA, Dickson ER, Lindor KD 1994 Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment.
Am. J. Gastroenterol. 89: 47-50.
-
Crocenzi FA, Basiglio CL, Perez LM, Portesio MS, Pozzi EJ, Roma MG 2005 Silibinin prevents cholestasis-associated retrieval of the bile salt export pump, Bsep, in isolated rat hepatocyte couplets: possible involvement of cAMP.
Biochem. Pharmacol. 69: 1113-1120.
*
-
Crocenzi FA, D'Andrea V, Catania VA, Luquita MG, Pellegrino JM, Ochoa JE, Mottino AD, Sanchez
| |
